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INTRODUCTION 
Glucose is the principal monosaccharide released at the intestinal 
surface and accounts for 80% of digested carbohydrates. It is absorbed 
partly by diffusion and partly by Na-coupled, Na^-K^-ATPase dependent 
active transport. 
Among cells, brain, heart, and less importantly kidney have high 
dependencies on glucose for their energy. Adipose, muscle, and liver 
cells, on the other hand, utilize both glucose and fatty acids as their 
energy sources. Glucose transport into peripheral tissues is so 
important in energy metabolism that, if it is defective, there will be 
deficiencies of energy and abnormalities in energy utilization and 
storage in cells. 
Glucose is transported into peripheral cells by facilitated 
diffusion which is catalyzed by an integral membrane protein, a 
transporter. By facilitated diffusion, glucose diffuses down in a 
glucose concentration gradient across cell membranes more rapidly than 
might be expected from its size, charge, or partition coefficients. 
The rate of diffusion can be saturated, and no metabolic energy is 
required even though the intracellular energy state could affect the 
overall rate of glucose transport. 
The rate of glucose transport into peripheral cells is accelerated 
physiologically by several factors; hormones, particularly insulin; 
several multivalent membrane active agents including lectins, 
antimembrane antibodies, and antireceptor antibodies; agents that cause 
membrane perturbations including phospholipases and proteases (19). 
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Glucose is phosphorylated as rapidly as it penetrates. When 
insulin is not available in the system, the transport itself seems to 
be the rate-limiting step for the over-all uptake of glucose. When 
insulin is added, intracellular phosphorylation of glucose seems to be 
the rate limiting step for the over-all uptake of glucose (63, 67). 
A high blood level of free fatty acids has been associated with an 
impaired glucose tolerance (79, 93) and decreased glucose utilization 
by peripheral tissues (80). On the contrary, a stimulatory effect of 
catecholamines on glucose transport has been reported (44, 45, 90). 
These conflicting results led to consideration of a factor which may be 
released into the incubation medium during stimulation of lipolysis and 
which mediates the effect of catecholamines in glucose transport. 
Prostaglandins(PG), thromboxanes (TX), and prostacyclins (PGI) 
comprise groups of polyunsaturated, hydroxylated 20-carbon fatty acids, 
called collectively eicosanoids. They can evoke a wide spectrum of 
biological reactions, at extremely low concentrations, in a variety of 
tissues. Eicosanoids per se have been implicated as playing functional 
roles in such physiological processes as vasodilatation and 
vasoconstriction, regulation of body temperature, platelet aggregation, 
reproduction, inflammation, gastrointestinal functions, autonomic 
neuro-transmission, and cardiovascular and renal functions. 
Eicosanoids are not stored within the cell, and it is widely 
believed that the rate limiting step in eicosanoid synthesis is 
precursor availability. Dietary manipulation of eicosanoid precursor 
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fatty acids can alter ^  novo synthesis of eicosanoids by altering the 
precursor availability at the cellular level (57). Relative amounts 
•and kinds of dietary fat are directly and proportionally reflected in 
the composition of depot and erythrocyte lipids. Very high levels of 
precursor fatty acids in the diet may cause high levels of eicosanoids 
to be produced in cells. 
Despite the myriad of biological and pharmacological properties of 
eicosanoids, relatively little is known of mechanisms by which these 
compounds act. This may be caused by their polyfunctional nature in a 
formidably wide spectrum of cellular effects. It is widely believed 
that the reaction site of eicosanoids is the membrane which houses 
specific sites for substrates similar to those of known hormone 
receptors and through which glucose is transported. 
Many researchers have shown that eicosanoids are involved in 
carbohydrate metabolism and regulation of the blood level of glucose by 
three mechanisms; the modification of insulin release from the 
pancreas, the uptake and utilization of glucose by peripheral tissues, 
and glucose metabolism in liver. However, reports about eicosanoid 
effects on glucose metabolism are equivocal which may be attributed to 
experimental designs and executions. Effects of eicosanoids on 
peripheral glucose transport have not been extensively studied. Most 
of published reports suggest that eicosanoids, including PGEi, PGE2, 
and TXA2, but not PGA^ or PGI2/ may have stimulatory roles in 
peripheral glucose transport. Effects of eicosanoids on peripheral 
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glucose transport seem to be varied depending on types and relative 
amounts produced (53, 71, 91). 
The overall objective of this research was to test the effects of 
endogenous eicosanoids on glucose transport into isolated fat cells 
using several modifiers of eicosanoid concentration. For this 
objective, rats were fed qualitatively different fats to serve as 
eicosanoid precursors, and fed aspirin to inhibit endogenous eicosanoid 
synthesis. Then ex vivo experiments were performed with isolated 
adipocytes harvested from rats fed experimental diets. Several in 
vitro treatments such as aspirin (a synthetic inhibitor of PG, TX, and 
prostacyclin production by an inhibition of cyclo-oxygenase activity), 
antiserum to PGE as a specific inhibitor of PGE, and norepinephrine (to 
stimulate release of eicosanoid precursors from fat cells) were also 
used to modulate eicosanoid concentration. Two-deoxy glucose uptake 
and free fatty acid release were measured during the incubation of 
adipocytes along with fatty acid composition in epididymal fat pads. 
Data of fatty acid composition of the fat pads, FFA released from the 
adipocytes, and eicosanoid levels in the adipocytes were treated 
statistically to find out relationships with glucose transport into 
adipocytes. 
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REVIEW OF LITERATURE 
Glucose Transport 
Glucose transporter 
Glucose transport across cell membranes involves a specific 
interaction between glucose and a membrane component, glucose 
transporter, which has been found in a variety of tissues including rat 
adipocytes (38), human placenta, human skeletal muscle cells, chick 
embryo fibroblasts, and human erythrocytes (1). The transporter 
carries glucose alone, driven by its concentration gradient, and it is 
different from the Na^-linked glucose transporter present in kidney and 
intestine. The transporter is a glycoprotein containing some 5%, by 
weight, sialic acid (86). 
Structures and activities of the glucose transporter have been 
examined after isolating them from cell membranes and reconstituting 
them into artificial phospholipid vesicles (1). The data demonstrate 
that the reconstituted adipocyte glucose transporter has an apparent 
radius of about 60-80 A° indicating a region capable of spanning the 
plasma membrane. It has binding sites at both membrane sites, outward-
facing and inward-facing. The reconstituted adipocyte glucose 
transporter also shows asymmetric kinetics for glucose uptake and 
efflux; the efflux has a four-fold greater maximum rate (Vjjj^jj) and four 
fold greater apparent affinity (K^a^) than the uptake processes (92). 
Using ^H-cytochalasin B, a reversible competitive inhibitor of glucose 
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transport, and an isoelectric focusing technique, Horuk et al. (38) 
found diverse glucose transporters different in isoelectric points (pH 
6.4 and 5.6) in the low-density microsomes of rat adipocytes. In 
contrast, the plasma membrane glucose transporter was structurally 
homogeneous on isoelectric focusing, and only a single isoform focusing 
at pH 5.6 was detected. Horuk et al. suggested that pH 6.4 glucose 
transporter isoform might represent an immature species which was 
converted to the mature pH 5.6 form by differential glycosylation 
probably involving terminal capping with sialic acid residues. 
Chromatographic properties of adipocyte glucose transporters in 
detergent solutions are different from those of insulin receptors. 
This result indicates that the glucose transport proteins may be 
associated with insulin receptor proteins by only weak, noncovalent 
means that are disrupted by mild detergent actions (18). 
The glucose transported into an extrahepatic cell is rapidly 
phosphorylated to glucose-6-phosphate by hexokinase activity; no free 
glucose accumulates inside the cell, and the rate of phosphorylation is 
limited by the rate of transport. In this state, the transport seems 
to be the rate-limiting step for the over-all uptake of glucose (16). 
When insulin is present, glucose transport is markedly stimulated; free 
glucose is found inside the cell. In this state, the accelerated 
transport by insulin exceeds the capacity of phosphorylation, which 
becomes the major limiting step for glucose transport (63). 
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Factors affecting adipocyte glucose transport 
Several agents with multivalent binding sites for the adipocyte 
plasma membrane such as lectins (concanavalin A and wheat germ 
agglutin) and antibodies to plasma membranes or insulin receptors 
enhance glucose transport while decreasing lipolysis (20, 55, 68). 
Czech and Lynn (19) found that the lectins, hemagglutinating 
substances that bind mannose-containing oligosaccharides, agglutinated 
the adipocyte membrane while increasing glucose transport. Even when 
the insulin binding to the brown adipocytes was completely blocked by 
trypsinization, lectin still enhanced 3-0-methylglucose transport 
compared with the control. Czech and Lynn suggested that the activity 
of lectin was mediated by affecting the D-glucose transporter, not by 
affecting insulin action. 
Various antibodies also enhance D-glucose transport by adipocytes. 
Pillion and Czech (68) reported that antibodies raised in rabbits 
against adipocyte plasma membranes enhanced 3-0-inethyl-glucose 
transport and CO2 production while decreasing lipolysis either in 
trypsinized or in non-trypsinized adipocytes. Kahn et al. (47) 
reported that circulating antibodies against insulin in patients of 
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acanthosis nigricans inhibited the binding of I-insulin to 
adipocytes while activating glucose transport. These results 
demonstrate that membrane events elicited by multivalent agents which 
bind to cell surface sites other than insulin receptors activate 
glucose transport. On the other hand, monovalent fragments of the 
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biologically active antibodies, prepared by papain digestion of the 
anti-membrane antibodies, were ineffective in enhancing glucose 
transport by adipocytes, suggesting that the ability of anti-membrane 
antibodies to enhance glucose transport by isolated adipocytes was 
dependent on the multivalent nature of the antibodies' structure. 
Glucose concentration around the adipocyte modulates glucose 
transport. The rate of glucose transport increases when glucose 
concentration in the medium increases up to 5 mM. At higher than 5 mM 
glucose, the transport curve becomes linear suggesting a passive 
diffusion (93). 
Phospholipase A has a biphasic effect on adipocyte glucose 
transport (3). At low concentrations such as lower than 3 wg/mL, it 
stimulates glucose transport by adipocytes; at high concentrations such 
as higher than 3 ug/mL, it inhibits glucose transport. Similar, 
concentration-related, biphasic effect of phospholipase C on adipocyte 
glucose transport has been also reported (75). 
Microviscosity of the membrane may affect glucose transport by 
adipocytes. Melchior and Czech (59) observed that the glucose 
transport activity in a reconstituted, membrane protein containing 
phospholipid vesicle containing adipocyte membrane protein was parallel 
to the increment of temperature from 0°C to 30°C at which the bilayer 
fluidity was maximal. Above 30°C, the transport activity was increased 
less markedly. Furthermore, when the reconstituted membrane vesicle 
was prepared with cholesterol, the microviscosity was increased while 
inhibiting glucose transport at 23°C. 
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The oxido-reductive state may affect glucose transport. Ludvigsen 
and Jarett (55) reported that oxidants such as H2O2 and diamide 
enhance, while reductants inhibit glucose transport by adipocytes. 
Insulin, a hormone produced by the beta cells of the islets of 
Langerhans in the pancreas and secreted into the blood as a direct 
response to hyperglycemia, plays a central role in the regulation of 
glucose transport by extrahepatic cells including adipocytes. The 
ability of insulin to stimulate glucose metabolism in adipose tissue 
was first observed by Winegard and Renold in 1958 (95). Later it was 
found that insulin caused a manyfold increase in the without 
altering the of glucose transport activity, suggesting that the 
stimulatory effect occurred at the glucose transport level (55, 93). 
In vitro studies with isolated rat adipocytes show that the onset 
of insulin's action takes up to 45 seconds at 37°C (83). The first 
step in the transfer of the messages of insulin into the cell is an 
interaction of insulin with its specific receptors on the membrane. An 
insulin receptor appears to be an integral membrane protein with a 
radius of 68-72 A°, comprised of 3-4 subunits, and it has an estimated 
molecular weight of 300,000 to 1,000,000 Daltons. The half life of an 
insulin receptor is about 16 min; it shows characteristics such as 
saturability, reversibility, specificity for substrates, pH dependency, 
temperature dependency, ion sensitivity, and negative cooperativity 
(46). 
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Morphologie studies show that insulin localizes to the plasma 
membrane producing a receptor-insulin complex, aggregates the membrane 
sites, and then the receptor-insulin complex is rapidly internalized 
into the cell. The endocytosed complex may be metabolized in the 
lysosome or recycled back to the plasma membrane (39) 
Only a small fraction of existing insulin receptor sites on the 
membrane have to be occupied to exert the maximal effect of insulin on 
glucose transport. Simpson and Cushman (83) reported that 0.1 to 1.0 
nM insulin caused 5 to 95 per cent of the stimulatory effect on 3-0-
methyl glucose transport into rat adipose cells. A half maximal 
stimulation was caused with 0.3 nM which corresponded to a receptor 
occupancy of about 10 per cent. This discrepancy between the cell's 
binding capacity for insulin and the amount of insulin required for the 
maximal action has given rise to the concept of spare receptors. 
On the other hand, the concentration of circulating insulin 
inversely regulates the number of insulin receptors (down regulation). 
This down regulation may be a factor of insulin resistance in which the 
insulin effect at the target cell is diminished. 
The mechanism by which insulin stimulates glucose transport is not 
clear yet. Recent work strongly suggests that insulin may increase the 
number of operational glucose transporters by translocating them from a 
non-operative, intracellular pool or by modifying the existing non-
operative transporters (39, 41, 83). These concepts are in accordance 
with earlier data that insulin enhances the V^gjj without altering the 
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Kjjjgjj Of the glucose transport curve (55, 93). However, little is known 
about the signals elicited by receptor binding of insulin and the 
activation of the glucose transporter. 
An increased concentration of plasma free fatty acids is 
associated with an impaired glucose tolerance as observed in patients 
with endocrine and metabolic disorders such as genetic diabetes 
mellitus, hormone induced diabetes, prolonged starvation, carbohydrate 
deprivation, and familial hyperlipoproteinemia (79, 93). Stimulation 
of lipolysis by agents increasing the activity of adenylate cyclase 
reduced binding and the effects of insulin on glucose transport (10). 
Moreover, short, medium, and long chain fatty acids, as well as their 
metabolites such as acetoacetate and g-hydroxybutyrate, inhibit 
peripheral glucose transport and utilization (80, 82). 
On the contrary, a stimulatory effect of catecholamines on glucose 
transport has been reported. First, Vaughan in 1961 (90) reported that 
lipolytic hormones, norepinephrine at 2.7 ug/mL, and epinephrine at 2.7 
wg/mL caused a 1.3- to 3-times increase in glucose transport by adipose 
tissue compared with the control values. Recently, many researchers 
have reported that ^-adrenoceptor agonists such as L-isoproterenol 
enhanced glucose transport by adipocytes. This enhancement was closely 
parallel to the stimulation of lipolysis and was abolished by 
propranolol, a beta adrenoceptor blocker (44, 45). 
In white adipocytes from hamster and human adipocyte tissue, it is 
possible to see beta^, beta2, alpha^, and alpha2 effects separately, 
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based on structure-activity relationships for agonists (26). 
Activation of beta adrenoceptor stimulates, while activation of alpha2 
adrenoceptor inhibits cyclic AMP and lipolysis. The cyclic AMP and 
lipolytic response to catecholamines may depend on the relative ratio 
of alpha2 to beta effects. Alpha^ adrenoceptors do not have known 
effects on lipolysis, rather their activities are associated with an 
elevated concentration of cytosolic calcium or with an elevated 
turnover rate of phosphatidyl inositol. It also stimulates glycogen-
phosphorylase activity and inhibits glycogen synthase activity via 
mechanisms distinct from those effects of adenylate cyclase activation. 
Norepinephrine is more potent than epinephrine in activating lipolysis. 
Norepinephrine released from sympathetic nerves may activate beta^ 
adrenoceptor to increase concentration of cyclic AMP and lipolysis. 
Epinephrine released from the adrenal medulla may activate betag 
adrenoceptor to increase cyclic AMP concentration and dilate blood 
capillaries supporting adipose tissue (26). 
Usage of nonmetabolizable glucose analogs 
The radiolabeled glucose analog, 2-deoity-D-glucose (2-DG), is 
transported into adipocytes and phosphorylated by hexokinase by the 
same process as D-glucose does. It cannot be further metabolized into 
CO2 or transformed into lipids and is trapped intracellularly. 
Theoretically, uptake represents the balance between influx and efflux. 
To assess initial transport rates, it is essential to measure influx 
under circumstances where efflux is minimal or non-existent. The 
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measurement of 2-DG transport provides an accurate assessment of 
glucose transport provided that the rate of phosphorylation by 
hexokinase is rapid enough to prevent any accumulation of non-
phosphor y la ted deoxyglucose, e.g., the transport itself is rate-
limiting. 
3-0-Methyl-D-glucose (3-OMG) is another glucose analog widely used 
to study glucose transport. However, unlike 2-DG, 3-OMG is not 
phosphorylated, and consequently, it is not trapped within the cell. 
Since the adipocytes' intracellular water space is comparatively small 
(2-4 per cent of the cell volume), the intracellular concentration of 
this sugar rapidly rises, leading to significant efflux at very early 
time points. Thus the initial rates of glucose transport must be 
measured within a few seconds (27). Shortening of the assay time may 
result in a considerable decrease in the sensitivity of the assay 
because of the problems of mixing the label with the cells and of 
stopping the 3-OMG transport without efflux of label. Olefsky (64) 
reported that 3-OMG transport kinetics showed a non-saturable process 
and might not completely reflect the D-glucose transport system. 
Furthermore, phloretin and phlorizin, which are often used in stopping 
3-OMG transport by adipocytes, have been reported to cause drastic 
effects on fat cell metabolism (22, 93). 
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Eicosanoid Metabolism 
The nutritional requirement of mammalian species for certain fatty 
acids was first recognized in young rats and described by Burr and Burr 
(6, 7). These investigators demonstrated that rats, maintained on a 
fat-free diet over a long period, developed an abnormality 
characterized by scaliness of the dorsal skin, the feet, and the tail. 
This abnormal skin later becaune necrotic. These signs were accompanied 
by growth retardation, impaired fertility, increased water consumption 
and diminished ufine production. Burr and Burr proposed that linoleic 
and possibly linolenic acids were essential fatty acids. On the other 
hand, arachidonic acid has been considered to be the principal 
unsaturated fatty acid required by the animal organism (84). This line 
of thought has been strengthened by reports from several investigators 
who have shown that linoleic and 7-linolenic acids undergo 
transformations in the animal organism to give arachidonic acid (70). 
Later studies have demonstrated that essential fatty acids can be 
transformed enzymatically into eicosanoids which act as local hormones 
and evoke a wide spectrum of biological reactions at extremely low 
concentrations in a variety of tissues. 
Synthesis of eicosanoids 
Linoleic acid is the most important dietary precursor of 
eicosanoids. It undergoes a single desaturation and a elongation step 
to form dihomo-7-linolenic acid which is the precursor of group one 
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(rnono-ene) prostaglandins, thromboxanes, and prostacyclins (these three 
groups of compounds are referred to herein as PG). Further 
desaturation produces arachidonic acid which is the precursor of group 
two (di-ene) PG. Alpha-linolenic acid is another dietary precursor of 
PG. It undergoes desaturation and elongation steps to produce 
eicosapentaenoic acid which is the precursor of group three (tri-ene) 
PG. Group two PG are physiologically the most important ones. 
Most cellular arachidonic acid is found in the membrane 
phospholipid fraction, and its release is facilitated by membrane bound 
phospholipase activities such as phospholipase A2 activity or 
phospholipase C activity followed by 1,2-diacyl glycerol hydrolase 
activity. Arachidonic acid is usually attached to the carbon two 
position of the phospholipid. 
Arachidonic acid is metabolized by two distinct pathways known as 
the arachidonic acid cascade producing the family of compounds called 
eicosanoids. Arachidonic acid is hydroxylated in one pathway by a 
cytosolic enzyme, fatty acid lipoxygenase, and produces unstable 
peroxygenated fatty acids such as hydroperoxy eicosatetraenoic acid 
(HPETE) which is reduced to hydroxy eicosatetraenoic acid (HETE). 
Peroxidation at C-5 also leads to the synthesis of a family of 
leucotrienes. Alternatively, arachidonic acid interacts with a 
membrane bound multienzyme complex, prostaglandin endoperoxide 
synthetase. This enzyme complex has two enzyme activities, fatty acid 
cyclo-oxygenase and prostaglandin hydroperoxidase activities. It 
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specifically catalyzes the incorporation of molecular oxygen into 
polyunsaturated fatty acids, generating 15-hydroxy prostaglandin 
endoperoxides (PGG^ and PGH2). Prostaglandin endoperoxides are the 
common precursors of group two PG (56). Prostaglandin endoperoxide 
synthetase seems to be present in all cell types and present 
intracellularly in the microsomal fraction (34). 
PGG2 and PGH2 are also biologically active compounds that induce 
platelet aggregation and mediate pressor effects on vascular smooth 
muscle. They are unstable (half-life approximately 5 min in smooth 
muscle at 37"C in aqueous solution) and are quickly isomerized to 
specific PG by specific synthetic enzymes (31, 32). 
Transformation of PGH2 to PGD2 is catalyzed by PGD2 isomerase, and 
transformation of PGH2 to PGE2 is catalyzed by PGE2 isomerase. PGD2 
isomerase and PGE2 isomerase are probably glutathione dependent 
enzymes. transformed from PGH2 by a non-enzymic process or 
from PGE2 by 9-keto-reductase (14, 96). 
The prostaglandin endoperoxides can also be transformed 
enzyraatically into two other unstable products with potent biological 
activities called thromboxane A2 (TXA2) and prostacyclin (PGI2). TXA2 
is the major product of arachidonic acid metabolism in platelets and 
prostacyclin is the major product of arachidonic acid metabolism in 
vascular tissues. TXA2 is a potent vasoconstrictor and inducer of 
platelet aggregation, while PGI2 is a powerful vasodilator and 
inhibitor of platelet aggregation. The balance of these two activities 
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appears to be important in cardiovascular functions (88). TXA2 is 
transformed from PGH2 by thromboxane synthetase. The compound is very 
short-lived (half-life of about 30 s in vitro and is quickly hydrolyzed 
to stable, but biologically inactive TXB2 (33). PGI2 is transformed 
from PGH2 by prostacyclin synthetase. This compound is also short­
lived (half- life of about 2-3 min at 37°C in blood) and is quickly 
hydrolyzed to stable 6-keto-PGFiQ (62). In addition, PGG2 and PGH2 are 
also precursors of a 3-carbon substance, malondialdehyde (MDA), and a 
17-carbon hydroxy acid, 12-hydroxy-5,8,10-heptadecatrienoic acid (HHT) 
( 8 8 ) .  
Eicosanoids are not stored in mammalian tissues, and various 
physiological or physical stimuli cause rapid biosynthesis of 
eicosanoids. It is generally considered that the availability of free 
arachidonic acid is the rate limiting factor in the formation of 
eicosanoids ^  vivo. The biosynthesis of eicosanoids is shown in 
Figure 1. 
Fatty acid composition of tissue lipids is affected by the fatty 
acid composition of dietary fats. Kinds of dietary fats can affect the 
availability of eicosanoid precursor acids and the synthesis of 
eicosanoids by altering the composition of endogenous precursor fatty 
acid pool (57). Evidence for this synthetic difference was 
demonstrated by reduced synthesis of eicosanoids in essential fatty 
acid deficient (EFAD) rats (13), elevated synthesis of eicosanoids in 
the high linoleic acid-fed rat (40, 57), and cleared dermal symptoms of 
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EFAD rats by topical application of PGE2 (98). In a review article, 
Mathias and Dupont (57) concluded that synthesis of eicosanoids can be 
depressed by biochemical essential fatty acid deficiency and enhanced 
when the linoleic acid to saturated fatty acid ratio (P/S) of the 
dietary fat was greater than 5. 
The trans-isomers of fatty acids produced during partial 
hydrogénation of fats have been reported to decrease synthesis of 
eicosanoids (9). And the presence of exogenous oleic, linoleic, 
elaidic, vaccenic, and a-linolenic acids were also inhibitory to the 
conversion of linoleic acid to 7-linolenic acid or to the conversion of 
3 
H-arachidonic acid to PGE2 in sheep vascular glands or in rat stomach 
in vitro. Alpha-linolenic acid caused the greatest inhibition (66). 
The inhibition probably was caused by a competition among fatty acids 
for desaturases or for prostaglandin synthetase (4, 37). 
Catabolism of eicosanoids 
Major sites of catabolism of eicosanoids are lungs, kidneys, 
intestines, liver, and placenta. However most eicosanoids seem to be 
catabolized at a place near to their synthesis (88). The main enzymes 
responsible for the biological inactivation of eicosanoids by 
converting the 15-hydroxy1 group into the keto form are generally 
termed 15-hydroxy-prostaglandindehydrogenases (15-OH-PGDH). These 
enzymes are generally present in mammalian tissues. Following the 
initial oxidation of the 15-hydroxyl group; 15-keto prostaglandins, 
thus obtained, undergo a NADH or NADPH dependent irreversible reaction 
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between C-13 and C-14 to form 15-keto 13,14-dihydro prostaglandins. 
The 15-keto 13,14-dihydro prostaglandins appear to be the initial major 
metabolites in the plasma. The enzyme responsible for this reduction 
13 is 15-keto prostaglandin A -reductase which is also present in most 
tissues. 
Fifteen-keto 13,14-dihydro prostaglandins are further catabolized 
by two cycles of the g-oxidation of the carboxyl side chain and by 
w-oxidation resulting in the excretion of C-16 dicarboxylic acids in 
the urine (88). 
Effects of aspirin on the synthesis of eicosanoids 
The pioneer studies by Vane (89) showed that non-steroidal anti­
inflammatory aspirin (acetylsalicylic acid) and indomethacin inhibited 
biosynthesis of PG from arachidonic acid by cell-free homogenates of 
guinea-pig lung. These reports stimulated the search and the 
evaluation of a variety of non-steroidal, anti-inflammatory drugs such 
as meclofenamic acid, indomethacin, mefenamic acid, flufenamic acid, 
maproxen, phenylbutazone, aspirin, and ibuprofen. The precise 
mechanism of the inhibitory action is still uncertain; however, these 
drugs block the initial stage of the prostaglandin endoperoxide 
synthetase either in a reversible or in an irreversible manner. 
Irreversible inhibitors can cause prolonged reduction of synthetic 
activity, and presumably, synthesis of new cyclo-oxygenase is necessary 
to produce PG. The reversible inhibitors such as indomethacin prevent 
the formation of PG only as long as the agents are present in a 
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sufficient concentration to compete with the existing pool of free 
substrates. Aspirin (acetylsalicylic acid) is an irreversible 
inhibitor, and it selectively acetylates the fatty acid cyclo-
oxygenase; 8-10 days are required for platelets treated with this drug 
to recover and to synthesize PG (76). 
Effects of Eicosanoids on Glucose Metabolism 
According to reports, eicosanoids influence glucose metabolism in 
several aspects: pancreatic insulin release, hepatic glucose 
metabolism, and peripheral glucose transport and metabolism. 
Effects of eicosanoids on insulin release 
Bressler et al. in 1968 (5) reported that PGE^ at 2.5 to 5 ug 
injection increased both plasma insulin and blood glucose in mice in 
vivo. Since then many investigators have studied the effects of 
eicosanoids on beta-cell function in a variety of investigative models. 
These models have ranged from monolayer cultures of islet cells to 
human investigation. 
In vitro experiments Johnson et al. (42) reported that PGEj_, 
PGE2, and PGF2q, but not PGAj^, enhanced release of insulin in isolated 
pancreatic islets which were incubated with high glucose media (300 
mg%). The effect of eicosanoids was dose related. PGE^, the effect of 
which was apparent at 10 ® M, was the most potent in stimulation of 
insulin release. However, even PGF2a and PGE2 caused nearly a twofold 
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-4 increase in glucose-stimulated insulin release at 10 M concentration. 
Burr and Sharp (8) also reported a stimulatory effect of PGE^ (0.3 
Mg/mL) on insulin release from perfused, isolated pancreatic islets of 
rats, in that experiment, PGE^ was effective only within media 
containing low glucose concentration (50 mg%); in the media containing 
high glucose concentration (300 mg), it rather inhibited the insulin 
release. 
Landgraf and Landgraf-Leurs (50) reported that PGF2a affected 
insulin release from isolated, perfused rat pancreas, but PGE2 did not. 
The effect of PGF2g was dose related; a low exogenous PGF20 (1 mM) was 
stimulatory while high PGF2^ (10 wM) was inhibitory. The total effects 
of endogenous eicosanoids were stimulatory in these experiments; 
1 2 
synthetic inhibitors of eicosanoids (indomethacin or raepacrine ) 
inhibited insulin release, while a treatment of catabolic inhibitor of 
eicosanoids (furosemide)^ stimulated it. 
Most ^  vitro studies showed that eicosanoids affect pancreatic 
insulin release in a positive manner. This effect of eicosanoids on 
insulin release may be closely related to the activation of the 
adenylate cyclase system. In fact, eicosanoids increase cyclic AMP in 
islets of Langerhans by increasing the activity of adenylate cyclase 
(50, 94). Glucose concentrations in the media and/or eicosanoid types 
^An inhibitor of PG endoperoxidase. 
2 
An inhibitor of phospholipase. 
^An inhibitor of PG dehydrogenase. 
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and concentrations may influence the effect of eicosanoids on insulin 
release. 
Experiments in intact animals Lefebvre and Luyskx (52) 
reported that PGEj^ infusion at the i.v rate of 1 wg/Kg/min for 40 min 
significantly stimulated insulin output in overnight fasted, 
anesthetized dogs, while a lower dose (0.5 wg/Kg/min) did not affect 
insulin output. Later, Schusdziarra et al. (81) found that the 
stimulatory effect of PGE2 on insulin release was transitory. When 
they infused PGE2 i.v. at 1 wg/Kg/min into anesthetized dogs for 50 
min, the insulin level in the pancreatic vein was gradually increased 
during the first 25 min and gradually decreased to the basal level 
during the later 25 min. In this study, PGE2 caused hyperglycemia even 
during the period of the elevated insulin level in blood. 
On the other hand, Sacca et al. (77) reported a lowering effect of 
exogenous PGEi, PGE2, and PGA^ at 2 #g/min on plasma insulin level. 
Robertson (72) also reported that infusion of PGE^ and PGE2 i.v. at 10 
«g/min in dogs decreased basal or glucose-induced insulin release. 
Experiments in humans Robertson and Chen (73) reported that 
the infusion of PGE2 at 10 ng/rain inhibited acute insulin response to a 
glucose pulse (i.v. 5 g) in normal people. Sodium salicylate, an 
inhibitor of endogenous eicosanoid synthesis, augmented acute insulin 
response to glucose pulse in normal people. Furthermore, in 
noninsulin-dependent diabetes (NIDDM) with fasting hyperglycemia, 
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sodiumsalicylate restored acute insulin response to glucose pulse. 
This restoration of acute insulin response to glucose pulse was 
accompanied by a four-fold augmentation in second phase insulin 
release. Giugliano et al. (29) reported that sodium salicylate 
infusion at 40 mg/min for 60 min caused a decrease in blood insulin 
levels in normal, healthy subjects? it did not affect blood insulin 
level in insulin-dependent diabetic patients. 
Ray et al. (69) reported a direct role of PGE^ and prostacyclin in 
the biological effect of insulin iji vitro. They showed that PGE^ or 
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prostacyclin at 3 nM increased the binding of I-labeled insulin to 
the human erythrocyte membrane preparation. Higher concentrations 
(above 8 nM) of the eicosanoid tended to reverse its effect on 
increasing insulin binding. A Scatchard analysis of the insulin 
binding to the erythrocyte membrane indicated that PGEj^ increased the 
binding capacity (V^^^) 2 times, without changing PGE2, either 
at 3 nM or 8 nM, decreased insulin binding» and other eicosanoids 
(PGA^, PGA2, PGB^, PGB2, PGD2, and PGF2^) had no effect. 
On the other hand, Szczeklik et al. (87) could not find any 
apparent effect of PGI2 infusion (i.v. 5 ng/Kg/min) of 72 h into non-
diabetic, cardiovascular disease patients on glucose-stimulated insulin 
response. Patients showed increased, or decreased, or non-affected 
results. 
Conclusions Studies have revealed conflicting data about the 
role of eicosanoids on insulin release; stimulatory as well as 
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inhibitory functions of various eicosanoids were observed. Considering 
the complex behavior of eicosanoids, the conflicting results are not 
surprising. However, the following factors should be considered in the 
study of eicosanoids effects on insulin release. 
1. The level of administration of eicosanoids through i.v. may 
not reflect their levels at the pancreatic cells, since 
eicosanoids are very quickly metabolized and normally do not 
circulate through the systemic blood system. 
2. Most studies used pharmacological rather than physiologic 
concentrations of exogenous eicosanoids which may exert 
diverse pharmacological effects in the body, and these may 
affect the pancreatic /3-cells function indirectly. 
3. The concentration of glucose in the area surrounding the 
pancreas may affect the role of eicosanoids in insulin 
release. 
Reported studies revealed significant effects of eicosanoids on 
pancreatic insulin release. Further studies are needed to confirm the 
role of eicosanoids on insulin release. 
Effects of eicosanoids on hepatic glucose metabolism 
Usually PGE^, PGE2, and PGI2 cause hyperglycemia when administered 
exogenously (78, 81). This hyperglycemic effect of eicosanoids could 
be explained by: increased glucose production of liver, decreased 
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glucose utilization of peripheral tissues, or both. Several 
investigators have reported that eicosanoids influence carbohydrate 
metabolism at the hepatic level (17, 78). Curnow and Nuttal (17) found 
that PGEi stimulated phosphorylase activity and decreased glycogen 
synthetase activity in isolated, perfused rat liver. 
Sacca et al. (78) reported that i.v. infusion, for 60-75 min, of 2 
wg/min of PGE^ and PGE2 into rats fasted for 18-20 h caused 
significant hyperglycemia. The rate of glucose turnover was calculated 
using the formula of Steele*, and the result showed that the 
hyperglycemia was due to an enhanced glucose production by liver. PGEj^ 
showed a more profound effect than PGE2 in causing hyperglycemia. The 
glucose uptake by peripheral tissues was also calculated; glucose 
uptake was immediately increased when the infusion of PGE^ or PGE2 was 
started, and kept increasing to reach the level close to that of 
hepatic output at the end of infusion. This finding suggests that PGE^ 
and PGE2 have regulatory roles on the level of blood glucose by 
stimulating glucose production by liver and glucose utilization by 
peripheral tissues. 
Since PGE^, PGE2, and PGI2 infusion cause modest hypotension, 
reflexly released catecholamine might secondarily cause the 
hyperglycemia. However, this possibility seems to be ruled out. PGI2 
infusion, at 5 ng/Kg/min into cardiovascular diseased or at 0.1-1.0 
^Steele's formula, after administering i.v. labeled glucose, 
calculates glucose turnover rate in the body by measuring the infusion 
rate, appearance rate in the blood, and the disappearance rate in the 
blood of the labeled-glucose. 
27 
Mg/Kg/min into healthy rabbits for 3 h, caused hyperglycemia in nearly 
all animals while causing hypotension in only 20% of them. These 
results suggest that the hyperglycemic effect of eicosanoids was not 
caused by reflexly released catecholamines. Furthermore, inhibitions 
of catecholamines by a depletion of catecholamine stores by reserpine 
or by administrating an a-adrenergic blocker, phentolamine, did not 
change the hyperglycemic effect induced by eicosanoids (72). 
Hyperglycemia is a common feature in diabetes. And the production 
of PGEi, PGE2, and PGF2a in the serum is increased in diabetic patients 
(43, 12). These elevated eicosanoids might be contributing factors to 
hyperglycemia by increasing hepatic glucose production in diabetes. 
Effects of eicosanoids on peripheral glucose transport 
Several papers have reported that eicosanoids have insulin-like 
effects on glucose metabolism in fat cells. Vajughan (91) demonstrated 
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an increase in glucose-U- C uptake and its conversion into glycogen 
and fatty acids by exogenous PGE^ (0.4 or 1.0 jug/mL) in rat adipose 
tissue in vitro. Later, several other researchers (11, 28, 97) also 
reported a similar, stimulatory effect of PGE^ on glucose transport by 
adipose tissue or into isolated adipocytes, ^  vitro. 
Richelson et al. (71) reported that exogenous PGE2 stimulated 3-0-
methyl glucose transport into, isolated human subcutaneous fat cells. 
(U-^^C)Glucose oxidation into CO2 and lipogenesis were also stimulated 
by PGE2. The effect of PGE2 was dose dependent and manifested as low 
as 0.8 nM concentration. In this study, indomethacin significantly 
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inhibited insulin-stimulated CO2 production in fat cells, whereas it 
had no effect on basal glucose metabolism. Exogenous PGFgQ^ tended to 
increase 3-0-methyl glucose transport which was not statistically 
significant. Lefebvre and Luyskx (53) reported that L8027 (pyridyl 
indolyl ketone, a specific inhibitor of TXA2 synthesis) decreased 
glucose transport by rat adipose tissue, suggesting a stimulatory 
effect of endogenous TXA2 on glucose transport. 
Begum et al. (2) also reported that endogenous eicosanoids 
stimulate intracellular glucose metabolism. Indomethacin treatment at 
3 iug/mL to the isolated adipocytes or particulate fraction containing 
mitochondria and plasma membrane of rat liver inhibited pyruvate 
dehydrogenase activity by approximately 62% as measured by ^^C02 
production from 1-^^C-pyruvate. PGE2 addition at 1.2X10~® M into the 
incubation system completely overcame the inhibitory effect of 
indomethacin. Dexamethasone, a glucocorticoid analog and an inhibitor 
of eicosanoid synthesis, at 1 mM also decreased insulin activation of 
pyruvate dehydrogenase activity which was partially restored by 
addition of arachidonic acid (0.2 jug/mL). 
PGEj|_ and PGE2 also stimulated glucose transport and metabolism in 
myometrium from rhesus monkeys (15), isolated stripped soleus muscle of 
rats (54), and canine thyroid tissue (65). But PGE2 and F2(^ suppressed 
(U-^^C)-glucose oxidation into ^^C02 in cultured mouse embryo (49). 
Szczeklik et al. (87) reported that the effect of PGI2 on 
peripheral glucose uptake was different between diabetic and non-
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diabetic subjects. Five to ten ng of i.v. PGI2/ administered to non-
diabetic but peripheral vascular disease patients, did not show a 
significant effect on glucose uptake ^  vivo. But an equivalent amount 
of PGI2» administered to diabetic patients, caused a decrease in 
glucose uptake by peripheral tissue. 
Summary Effects of eicosanoids on peripheral glucose transport 
have not been extensively studied. Most of the published reports are 
suggesting that eicosanoids, including PGE^, PGE2, and TXB2, but not 
PGAj_ or PGI2, may have stimulatory roles in glucose transport by 
adipocytes. Effects of eicosanoids on peripheral glucose transport 
seem to be varying depending on types and relative amounts of 
eicosanoids produced. 
Hypothesis 
Eicosanoids are involved in glucose transport into adipocytes. 
The quantity of dietary C18:2 affects eicosanoids and may affect 
glucose transport. 
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EXPERIMENTAL DESIGN 
One-month-old Zucker rats (twenty rats per experiment, 10 rats per 
diet, 5 rats per diet group) were fed iso-nutrient diets high (HSO) or 
low (LSO) in safflower oil for one month. After one month, five rats 
per diet group were fed aspirin for two days at 50 mg/Kg bw/day (ASP 
group), and the remained 5 rats in the same diet group were continued 
on the previous diets (HSO or LSO) without aspirin (CON group). At the 
end of one month feeding, there were four diet groups (HSO-CON, HSO-
ASP, LSO-CON, LSO-ASP). Experiments were repeated four times. 
TABLE 1. Experimental design 
In vivo In vitro 
Diet Group Adipocyte Treatment 
High 18J2 (HSO) + Asp (ASP) + Norepinephrine (N) 
- Asp (CON) + Aspirin (Asp) 
+ Anti-PGE (AntiE) 
Low 18:2 (LSO) + Asp (ASP) + Asp X Norepi (AspN) 
+ AntiE X N (AntiEN) - Asp (ASP) 
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Epididymal fat pads from 5 rats in each diet group were removed 
and pooled. Part of the fat pad was used to analyze fatty acid 
composition. Part of it was used for isolating adipocytes and 
performing in vitro glucose transport studies. The isolated adipocytes 
were distributed into 8 flasks and incubated with eicosanoid modifiers 
(norepinephrine, N; aspirin, Asp; antiserum to PGE, AntiE; and 
combinations of Asp x N, or AntiE x N) for 15 min. During the 
incubation, 2-DG transport and free fatty acid release were measured. 
Data were analyzed statistically to test the effect of diets on the 
composition of fatty acids of epididymal fat pads, the effect of the 
composition of fatty acids of fat pads on the composition of fatty 
acids released from isolated adipocytes, the effects of diets on the 
glucose transport into isolated adipocytes, and the effects of fatty 
acids released from isolated adipocytes on the glucose transport into 
adipocytes. The statistical methods used were Analysis of Variance, 
General Linear Models Procedure, and Least Significant Difference, at a 
5% levels of probability. Pearson Correlation Coefficients were also 
determined and were deemed significant if the r>0.5 and P<0.05. 
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METHODS AND MATERIALS 
Animals and Care 
In all the studies, non-obese, male Zucker rats raised in the 
stock colony of Iowa State University, Food and Nutrition Laboratory 
were used. One-month-old rats were individually caged in stainless 
steel cages, subjected to a 12 h light-dark cycle (0600-1800h light), 
and maintained at 24°C and 50% relative humidity. Twenty rats per 
experiment were evenly distributed into two experimental diet groups to 
give the same mean initial body weights between dietary groups. Rats 
were fed test diets which were different only in lipid qualities. High 
safflower oil diet (HSO) contained 20% of total calories from safflower 
oil as the only fat source. Low safflower oil diet (LSO) contained 2% 
of total calories from safflower oil and 18% from beef tallow (Table 
2 ) .  
At the end of 4 weeks feeding, 5 rats per diet group were fed 
aspirin at 50 mg/Kg bw/day for 2 days (ASP group). The remaining rats 
were continued on their previous HSO or LSO diet (CON group). The 
amount of aspirin in the diet was precalculated for each rat from its 
daily food intake to provide 50 mg/Kg bw/day. Actual aspirin intake 
per Kg bw per day (mean + SEM, n=20) was 47.00+2.74 mg in the HSO group 
and 48.17+1.83 rag in the LSO group. Diets were provided fresh twice 
weekly, and tap water was provided fresh every day ad libitum. Animals 
were weighed weekly, and food intakes were recorded. Aspirin was 
purchased from Sigma (St. Louis, MO). 
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TABLE 2. Composition of diet 
Ingredients HSO LSO 
g/100 g 
Casein^ 15.8 16.8 
1-Methionine^ 0.2 0.2 
Corn starch^ 32.6 32.6 
Sucrose*" 32.6 32.6 
Cellulose^ 2.2 2.2 
Salt mix® 4.4 4.4 
Vitamin mix^ 1.0 1.0 
Saf flower oil^ 9.3 1.1 
Beef tallow^ 0.0 8.2 
mg/100 g 
PABA^ 83.8 83.8 . 
Inositol^ 165.0 165.0 
Cholinechloride^ 331.8 331.8 
a-Tocopherol^ 212.8 212.8 
^United States Biochemical Co., Cleveland, OH. 
^Argo, Best Foods CPC International Inc., Englewood 
Cliffs, NJ. 
''Californian and Hawaiian Swgar Co., San Francisco, CA. 
^Teklad, Madison, WI. 
®ICN Nutritional Biochemicals, Cleveland, OH, AIN 
Mineral Mixture 75; calcium phosphate dibasic 500.0 gm; sodium 
chloride 74.0 gm; potassium citrate monohydrate 220.0 gm; potassium 
sulfate 52.0 gm; magnesium oxide 24.0 gm; manganous carbonate 3.5 gm; 
ferric citrate 6.0 gm; zinc carbonate 1.6 gm; cupric carbonate 
0.3 gm; potassium iodate 0.01 gm; sodium selenite 0.01 gm; chromium 
potassium sulfate 0.55 gm; sucrose, finely powdered 118.0 gm per 
Kg mixture. 
^ICN Nutritional Biochemicals, Cleveland, OH., AIN 
Vitamin Mixture 76; thiamine HCl 600 mg; riboflavin 600 mg; 
pyridoxine HCl 700 mg; nicotinic acid 3 gm; d-calcium pantothenate 
1.6 gm; d-biotin 20 gm; cyanocobalamin 1 mg; retinyl palmitate pre-mix 
(250,000 U/gm) 800 mg; dl-a-tocopheryl acetate pre-mix (25 U/gm) 
20 gm; cholecalciferol (400,000 U/gm) 2.5 mg; menaquinone 5.0 mg; 
folic acid 200 mg; sucrose finely powdered 972.9 gm per Kg mixture. 
^Hollywood Health Foods, Los Angeles, CA. 
^Meat Lab., Dept. of Animal Sciences, Iowa State 
University. 
^Nutritional Biochemicals, Cleveland, OH. 
^Sigma, St. Louis, MO. 
35 
Cell Isolation 
During ether anesthesia, epididymal fat pads from 5 rats in the 
same diet group were removed and pooled. The mean (n=8), pooled 
epididymal fat pad weights were 10.4 g and 11.2 g in the HSO and LSO 
groups, respectively. The difference was not statistically 
significant. Part of the fat pad was stored to be used for fatty acid 
analysis; part of the fat pad was subjected to isolation of individual 
adipocytes using collagenase following the method of Rodbell (74). The 
fat pads were rinsed in Krebs Ringer Bicarbonate (KRB) buffer 
containing 3% bovine serum albumin (BSA), pH 7.4. The tissue pieces 
were then gently taken apart with forceps into small pieces, placed 
into 25 mL polypropylene beakers containing the following collagenase 
digestion mixture, 30 mg BSA and 1 mg collagenase per mL KRB. Two mL 
of the digestion mixture was used per g of tissue. The beakers were 
placed in a metabolic shaker at 37°C and gassed with 95% C02-5% O2. 
The digestion mixture was filtered through a 250 Mm nylon screen with 
KRB rinses. The crude cell suspension was centrif/iged (50 x g for 1 
min), washed 2 times and resuspended in KRB containing 3% BSA, pH 7.4. 
The number of isolated cells and their viability was determined 
microscopically using a hemacytometer and 0.01% trypan blue solution. 
In all cases, the cell viability was found to be greater than 95%. The 
volume of the cell suspension was adjusted to 25.0 mL which contained 
5 5 
about 1.3X10 to 6.9X10 cells per mL suspension. 
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The microscopic cell counting method was verified for its accuracy 
by comparing its results with results of Coulter counter measurements 
of the same adipocyte preparation. For this comparison, one-month-old 
rats were fed either the HSO or LSO diet for 1 month; individual 
adipocytes were isolated, and counted by microscope using trypan blue 
dye and by Coulter counter after fixation of cells with OSO4 as 
follows: an aliquot of the cell suspension was fixed in 2% OSO4 in 
isotonic, 50 mM-collidine buffer, pH 7.4, for 48-72 h at room 
temperature (36). The fixed adipocytes were filtered through a 250 u 
nylon screen, and the filtrate was refiltered through a 25 m screen. 
Adipocytes on the top of a 25 m screen were then taken up in a known 
volume of 0.9% NaCl-0.004% Triton X-LOO for counting in a Coulter 
counter particle size analyzer using a 400 m aperture. A model Z 
Coulter Counter was used. The two counting methods gave similar 
results, and statistical treatment showed a very close relationship 
between counts by the two methods (r=0.99, P<0.001). The mean cell 
size in, diameter) was 74.63 in the HSO group and 75.90 in the LSO 
group. The difference was not statistically significant. The cell 
size approximated the upper limit of accurate analysis using the 
microscopic technique. Greater cell size would have resulted in 
distortion of the cells in the counting chamber and inaccurate results. 
Osmium tetroxide (OsO^) was obtained from Electron Microscopy 
Sciences (Fort Washington, PA). Nylon filtration screens were obtained 
from Tetko (Elmford, NY). Bovine serum albumin (Fraction V) was 
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obtained from Sigma (St. Louis, MO). Gas (95%02-5% CO2) was obtained 
from Cooks Inc. (Algona, lA). Polypropylene flasks and other chemicals 
were obtained from Fisher Scientific Co. (Springfield, NJ). 
2-Deoxy Glucose Transport 
Incubation time 
The optimum incubation time for 2-DG transport into isolated 
adipocytes was decided in a preliminary experiment. As shown in Figure 
2, the rate of 2-DG transport into adipocytes was increased linearly 
with time of incubation for a period of 15 min. After 15 min of 
incubation, the rate of 2-DG transport into adipocytes slowed, and the 
reaction curve became curvilinear suggesting that some efflux of 2-DG 
was occurring. Based on this result, cells were incubated for 10 rain 
in the 2-deoxy glucose transport experiment. 
Incubation cell number 
The cell number in the incubation mixture for optimum conditions 
for 2-DG transport study was also tested (Figure 3). Varied numbers of 
cells per mL of incubation mixture were incubated for 15 min, and 2-DG 
transport was measured. The results showed that 2-DG transport was 
increased linearly with the increase of the number of fat cells up to 
4.2X10^ cells per mL of incubation mixture. Based on this result, 
4 5 
4X10 to 4x10 cells per mL of incubation mixture was desired in later 
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FIGURE 2. Effect of incubation time on adipocyte 2-deoxy glucose 
transport of rats. 6.2X10 ce&ls per ml were preincubated 
for 30 min and incubated at 37 C 
experiments. Actually, in experiments, the incubation mixture 
contained 3.9X10* to 3X10^ cells per ml. 
2-DeoKy glucose transport protocol 
Six incubation flasks which contained 400 m1 of prepared cell 
suspension, 400 al KRB, 3% BSA, pH 7.4, with or without aspirin were 
placed in a metabolic shaker at 37®C for 30 min and gassed with 95% 
02-5% CO2. Measurements of 2-DG transport were initiated by addition 
of test mixtures. By adding test mixtures, the final incubation 
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FIGURE 3. Effect Of cell numbers on adipocyte 2-deoxy glucose 
transport of rats. Adipocytes were preincubated for 30 min 
and incubated for 15 min at 37°C 
mixture contained 2-deoxy-D-(l- H)-glucose at 2.0 wCi, 
inulin-(^^C)carboxylic acid at 0.5 wCi, 2-deoxy-D-glucose (2-DG) at 0.1 
mM and BSA at 30 mg/mL. The final incubation mixture also contained 
modifiers of eicosanoid synthesis. Norepinephrine at 10~^ M, Asp at 23 
mM, and antiserum to PGE at 167 and combinations of these were 
used as modifiers of eicosanoid synthesis. The incubation flask 
without any modifiers of eicosanoids was used as control. 
The amount of antiserum to PGE used was to bind most PGE produced 
in the cell incubation system as estimated from a preliminary 
experiment. 
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A sample of 200 m1 of incubation mixture was taken at 2, 5, and 10 
min and layered on 1 mL silicone oil containing tubes. The reaction 
was stopped by separating adipocytes from the media according to the 
methods of Gliemann et al. (30). This was accomplished by centrifuging 
the tube at 3,000 x g for 1 rain. Adipocytes were removed from atop the 
oil with a plastic-tipped automatic pipet and placed into scintillation 
vials. Fifteen mL of scintillation solution was added to each vial and 
radioactivity was determined by counting on a liquid scintillation 
counter (Tri-carb liquid scintillation Spectrometer, C2425, Packard 
Instrument Co., Downer's Grove, IL.). Extracellular space was 
calculated using ^^C-inulin as the marker and used in subtracting 2-DG 
that was not transported into cells but trapped extracellularly. The 
mean, trapped 2-DG in extracellular space was 15.93 + 8.91% (mean + 
SEN) of the total amount of the radiolabelled 2-DG found in the packed 
cell at the 10 min incubation time. Reaction rates were plotted as 
nanomoles 2-DG transport per 10^ cells vs. incubation time. The 
quenching effect of the sample in the liquid scintillation counting was 
corrected by using quenching curves developed with the fat cell 
incubation mixture. 
Silicone oil (d=0.943) was obtained from Aldrich (Milwaukee, WI). 
2-deoxy-D-(l-^H)-glucose and inulin-(^^C)-carboxylic acid were obtained 
from Amersham (Arlington Heights, IL). Two-deoxy-D-glucose, 
collagenase, and norepinephrine bitartrate were obtained from Sigma 
(St. Louis, MO). Scintivers Bio-HP and other chemicals were obtained 
from Fisher Scientific Co. (Springfield, NJ). 
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Eicosanoid Analysis 
Eicosanoids were quantified in adipocyte incubation mixtures. 
PGE-l, PGE2f PGF2a' 6-keto-PGFig (a stable product of PGI2), and TXB2 (a 
stable product of TXA2) were measured by radioimmunoassay as described 
by McCosh et al. (58). Briefly, the method involved an overnight pre-
precipitation of anti-rabbit gamma globulin with the specific antibody 
followed by a 24-h precipitation with sample and tritiated standard 
eicosanoids. Radioactivity in the precipitation was measured using a 
liquid scintillation counter and converted into amount of eicosanoids 
presented in the sample. 
The PGEi antiserum had a cross reactivity of 10% with PGE2, and 
PGE2 antiserum had a cross reactivity of 20% with PGEj^. The other 
eicosanoid antisera did not show cross reactivities with each other. 
Parallelism of each eicosanoid in fat cell incubation mixtures was 
checked. 
Tritiated PGE^, PGE2, PGF2q, and TXB2 were purchased from New 
England Nuclear Co. (Boston, MA). Tritiated e-keto-PGFj^^ was purchased 
from Amersham (Arlington Heights, IL). Standards were a gift from the 
Upjohn Company (Kalamazoo, MI). 
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Fatty Acid Analysis 
Extraction 
Composition of total fatty acids were determined in the epididymal 
fat pads. Fatty acid extraction of tissue, prior to fatty acid methyl 
ester preparation, involved saponification of 50 mg epididymal adipose 
tissue with 2 mL of 10% KOH/EtOH at 60°C for 1 h. After the 
saponification, 2 mL of H2O was added, and saponifiable fatty acids 
were extracted three times with 4 mL portions of petroleum ether. The 
aqueous phase was then acidified with concentrated HCl, and fatty acids 
were extracted three times with 4 mL portions of petroleum ether. The 
combined fatty acid extracts were evaporated to dryness under nitrogen 
and methylated for 2 min with boron tri-fluoride methanol (BFg/MeOH at 
14% W/V) at 100°C. The methylated fatty acids were extracted after 
addition of 1.0 mL distilled water and 2.0 mL hexane, and the organic 
phase was dried under nitrogen, and hexane (3 mL) was added to dissolve 
the methylated fatty acids. 
Free fatty acids (FFA) were quantified in adipocyte incubation 
mixtures. The method consisted of a total lipid extraction using the 
Dole reagent (23) and a two-phase alcoholic extraction of fatty acids 
follwing extraction of non-polar and basic lipids. The total lipid 
extraction required 2 mL adipocyte incubation mixture, 60 nl 
heptadecanoic acid solution (4 rag/mL, internal standard), 10 mL Dole 
reagent (heptane!isopropanol:l N H^SO^ = 1:4:0.1 by volume). After 5 
min of vigorous shaking and 5 min of standing, 6.0 mL of heptane and 
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4.0 mL of water were added. The organic phase was separated by 
centrifwgation at 3,000 x g, and the alcoholic phase was made basic 
with 1 N NAOH. The non-polar and basic lipids were extracted twice in 
heptane. The alcoholic phase was then acidified with 1 N HCl, and the 
FFA was extracted twice in heptane. The combined FFA extracts were 
subjected to fatty acid methyl ester preparation as described for fat 
pads. The final resuspended sample volume was 100 m1 for free fatty 
acid methyl esters. Heptadecanoic acid was obtained from Sigma (St. 
Louis, MO). BFj/MeOH was obtained from Alltech (Deerfield, IL). 
Teflon linings were obtained from Arthur H. Thomas Co. (Philadelphia, 
PA). 2-Propanol, petroleum ether, and other reagents were obtained 
from Fisher (Springfield, NJ). 
Gas chromatography 
A Beckman Gas Chromatograph GC 72-5 equipped with a CRS-208 
Columbia Scientific Integrator and a model 20 Texas Instruments 
Recorder was used for analysis of the fatty acid methyl esters. A 183 
X 0.32 cm stainless steel column packed with Alltech 10% CS-10 on 
100-120 WAW (Alltech, Deerfield, IL) was used. Instrument settings 
were as follows; column temperature, 180°C; injection port temperature, 
220°C; detector temperature, 250°C; line temperature 220°C. 
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Statistical Analysis 
Data were analyzed statistically using Analysis of variance 
(ANOVA) and General Linear Models Procedure (GLM), and means were 
compared by Least Significant Difference (LSD) at a 5% level of 
probability. Means are reported with the standard error of the mean 
(SEM). Group means are reported with pooled SEM if the variance 
between treatment was homogeneous by Bartlet's test (85). There were 
large variabilities in glucose transport data from experiments of in 
vitro treatments. This might be caused by daily variability between 
adipocyte preparations. To eliminate this daily variability between 
adipocyte preparations, data of in vitro treatments of eicosanoid 
modifiers on 2-DG transport were expressed as the ratio to the control 
level within each preparation. Correlation coefficiencies were also 
determined and were deemed significant if the r>0.5 and p<0.05. 
Preliminary Experiments 
Effect of norepinephrine on free fatty acid release 
Adipocytes, isolated from epididymal fat pads of Zucker rats,® 
7 
were incubated with or without norepinephrine at a final concentration 
-5 
of 10 M for 30 min. After a 30-min incubation, norepinephrine 
stimulated release of the total free fatty acids by 1.7-times (n=l) the 
®Rats were fed with Teklad laboratory rat chow containing 6% fat. 
^See "Methods and Materials" for detail. 
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30-min control values and by 3.2-tinies the O-min control values (Table 
3). 
Norepinephrine tended to increase absolute amounts of all 
individual free fatty acids, measured in the incubation mixture, except 
myristic and arachidonic acids during the 30-min incubation. Linoleic 
acid was increased by 1.5-times over 30-min control and by 2.2-times 
over O-min control values. These results show that prostaglandin 
precursors are actively released during norepinephrine-treated 
lipolysis vitro. 
Effect of norepinephrine on eicosanoid synthesis 
Amounts of eicosanoids, produced from isolated adipocytes during a 
30 min incubation of isolated adipocytes with or without norepinephrine 
-5 g 
at 10 M, were measured (n=l, values were estimated from range tests) 
(Table 4). 
At the basal level, isolated adipocytes produced PGE^^, PGE2, TXB2, 
PGF2a, and PGI2 (measured as 6 Keto-PGFig) of a total of 215.1, 237.4, 
93.6, 147.4, and 236.0 pg per 10® cells during a 30-min incubation. 
Norepinephrine-treated adipocytes produced PGE^^, PGE2, PGF2a by 1.64-, 
1.28-, and 1.4-times above the control levels. The synthesis of PGI2 
and TXB2 were not changed by the norepinephrine treatment. These 
results suggest that norepinephrine stimulated the synthesis of 
eicosanoids by enhancing the availability of eicosanoid precursors via 
active lipolysis. 
O 
See "Methods and Materials" for detail. 
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TABLE 3. Free fatty acid (FFA) release of control (Con) 
and norepinephrine (Norepi) stimulated 
adipocytes 
Incubation time 0 min 30 min 
Con Con Norepi 
FFA 
wg/10® cells 
14:0^ 4.1 30.2 8.9 
16:0 208.8 711.3 1099.3 
18:0 • 27.3 40.5 84.6 
18:1 207.9 249.8 562.6 
18:2 234.6 336.6 510.6 
18:3 15.3 9.4 24.4 
20:4 16.9 10.4 8.4 
Total FFA 714.9 1388.2 2298.8 
n=l. Isolated adipocytes from epididymal fat ggds 
were preincubated with or without norepinephrine (10 M) 
at 37degrees.C for 30 min. 
^Number of carbons :number of double bonds. 
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TABLE 4. Eicosanoid synthesis in isolated rat adipocytes incubated 
with (Norepi) or without (Con) norepinephrine^ 
PG PGEI PGEG TXBG PGF20 GKPGFIG 
Treatment 
pg per 10® cells 
Con 158.4 194.7 70.8 122.6 178.2 
K 0 min 
Con 215.1 237.4 93.6 147.4 236.0 
x30 min 
Norepi 353.3 303.8 99.8 203.3 237.2 
x30 min 
^n=l. Values were estimated from range tests. Adipocytes 
were preincubated for 30 min and incubated with or withoout 
norepinephrine (10 M) at 37°C. 
Effect of aspirin dosage on eicosanoid synthesis 
Six, two-months-old, male, Zucker rats were fed either high-fat 
(Hfat) or low-fat (Lfat) diet with aspirin for two days. Hfat diet 
contained 40% of calories from safflower oil as the only fat source, 
and the Lfat diet contained 2% of calories from safflower oil as the 
only fat source. Diets were formulated following the method of Dupont 
(25) to equalize nutrient density and were mixed with aspirin to 
provide either 50 mg/Kg/day or 100 mg/Kg/day. After 2 days' feeding, 
fat pads from 2 rats per group were pooled, fat cells were isolated, 
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preincubated for 30 min, and incubated for another 30 min. At the 30 
min incubation time, PGE^, TXB2, and PGI2 were measured in the 
Û 
incubation mixtures (n=l). At the 30-min incubation time, isolated, 
control adipocytes produced 154.6 pg PGEj^, 97.8 pg TXB2, and 172.5 pg 
PGI2 per 10® cells. 
Aspirin feeding caused inhibition of PGE^ production by 34-64% and 
TXB2 production by 53-72%. However, PGI2 concentration in the 
incubation mixture was not changed by aspirin feeding. The higher dose 
of aspirin (100 mg/Kg/day) was not more effective than the lower dose 
(50 mg/Kg/day) in decreasing productions of eicosanoids. Based on 
these results, rats were fed with aspirin at 50 mg/Kg/day in later 
experiments. This dose of aspirin was reported as safe and does not 
interfere with the normal growth of weanling rats for a 15 days' 
feeding (60). 
Preliminary feeding study 
Eight, weanling Zucker rats were fed either Hfat or Lfat diets for 
2 months. At the end of feeding, 2 rats/diet were fed aspirin at 50 
mg/Kg/day for 2 days. Fat pads from two rats were pooled, and fat 
cells were isolated. Isolated fat cells were incubated with or without 
-5 
norepinephrine (10 M) and anti-PGE (167 ul per 1,600 izl) plus 
—5 
norepinephrine (10 M). PGE2, TXB2, and 2-DG transport were analyzed 
^See "Methods and Materials" for detail. 
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in cell incubation mixtures during a 30-min incubation. 
Effect of diet on adipocyte glucose transport Isolated adipocytes 
from the Lfat group had greater glucose transport than those from the 
Hfat group. At the 15-min incubation time, adipocytes from Lfat group 
transported 3.96 nanomoles (2.4-times the HSO, n=l) and adipocytes from 
Hfat group transported 1.63 nanomoles 2-DG into 10® cells. Supposedly, 
adipocytes from the Hfat group produced more eicosanoids than 
adipocytes from the Lfat group; the observed result was contradictory 
to several reports about stimulatory effects of prostaglandins on 
adipocyte glucose transport in vitro. Not only fat difference but also 
carbohydrate difference in the diet might affect the glucose transport 
into adipocytes. The Lfat diet contained approximately 1.5-times more 
carbohydrate by weight than the Hfat diet in compensating the low 
energy level of the Lfat diet. Lavau et al. (51) also reported 
similar, lower glucose transport rates of isolated adipocytes from rats 
fed a high-fat diet compared with the adipocytes from rats fed a low-
fat diet. In their study, two diets provided almost the same amount of 
protein, and the energy level was equilibrated with contents of 
carbohydrates; the low-fat diet contained 70% carbohyrate by weight 
while the high-fat diet contained 10% carbohydrate by weight. 
Based on this result, iso-nutrient diets varying only in fat 
qualities were used in later experiments. Two dietary fat qualities 
were to be used to alter eicosanoid precursor availabilities in 
^^See "Methods and Materials" for detail. 
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adipocytes, thereby, to alter cellular production of eicosanoids. 
Effect of aspirin feeding on adipocyte glucose transport 
Aspirin feeding decreased glucose transport into isolated adipocytes in 
both diets compared with the control values. At the 15-min incubation 
time, this decrement was approximately 16% in the Hfat group and 38% in 
the Lfat group (n=l). The results suggest that the effect of 
endogenous eicosanoids on adipocyte glucose transport is in a positive 
direction. 
Effects of norepinephrine and anti-PGE on adipocycyte glucose 
_5 
transport Norepinephrine, at a concentration of 10 M, affected 
glucose transport into adipocytes very little compared to controls. At 
the 15-min incubation time, norepinephrine decreased glucose transport 
by only 2% in adipocytes from the Lfat group and 9% in adipocytes from 
the Hfat group (n=l). 
On the other hand, anti-PGE clearly decreased glucose transport 
into adipocytes. At the 15-min incubation time, anti-PGE plus 
norepinephrine decreased glucose transport by 17% in Hfat group and by 
27% in Lfat group. These results suggest that endogenous PGE enhanced 
glucose transport into adipocytes. 
Effect of killing methods on eicosanoid synthesis 
PGE2 and TXB2 synthesis were measured in isolated adipocytes 
harvested from rats grown on either Hfat or Lfat diet during a 30-min 
incubation. As shown in Figure 4, the synthesis of PGEg and TXB2 in 
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adipocytes were irregular to incubation time. During a 30-min 
incubation, PGE2 synthesis was increased in the control (CON) groups 
and decreased in the norepinephrine (N) groups; TXB2 synthesis was 
increased in the Hfat groups but decreased in the Lfat groups. The 
effect of norepinephrine on eicosanoid synthesis was also varied 
irregularly. At the 5-min incubation time, norepinephrine-treated 
adipocytes produced more PGE2 compared with the controls in both diet 
groups (Hfat and Lfat) as expected. However at the 30-min incubation 
time, norepinephrine-treated adipocytes produced less PGE2, compared 
with the controls, in both diet groups. These results were different 
from previous results (Table 4); synthesis of PGE2 and TXB2 were 
consistently increased during a 30-min incubation, which was true for 
all other eicosanoids measured (PGE^, ^Qi?2a' 6-keto-PGFig); 
norepinephrine-treated adipocytes produced more PGE2 compared with the 
control during a 30-min incubation, which was also true for PGE^ and 
PGF2Q synthesis. The difference between the two experimental 
procedures was only the method of rat killing. In other times, 
epididymal fat pads were removed during light ether anesthesia. This 
time, epididymal fat pads were removed after decapitation. Based on 
this result, ether anesthesia rather than decapitation and 
exsanguination was used in later studies. 
The difference between the two experimental procedures was only 
the method of rat killing. In other times, epididymal fat pads were 
removed during light ether anesthesia. This time, epididymal fat pads 
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were removed after decapitation. Based on this result, ether 
anesthesia rather than decapitation and ejtsanguination was used in 
later studies. 
In this preliminary experiment, aspirin feeding decreased 2-DG 
transport into adipocytes and decreased PGE^, PGE2, TXB2, and PGF2a. 
Anti-PGE treatment in vitro also decreased glucose transport into 
adipocytes. 
On the other hand, norepinephrine treatment jji vitro did not show 
a clear effect on glucose transport into adipocytes. If free fatty 
acids were inhibiting glucose transport into cells as described in 
"Review of Literature", the observed results might come from certain 
substances which were produced during norepinephrine-treated lipolysis 
and which compensated for effects of free fatty acids in decreasing 
glucose transport. 
These results suggest that endogenous eicosanoids may have a 
stimulatory role in glucose transport into adipocytes. Based on these 
results, a set of experiments was planned and performed to test the 
effects of endogenous eicosanoids on glucose transport into adipocytes. 
Herein the findings are reported. 
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RESULTS 
Accumulated Food Intakes 
The accumulated food intakes of rats fed the HSO or LSO diets for 
one month are presented in Figure 5. 
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FIGURE 5. Accumulated food intakes of rats fed diets different in fat 
qualities. HSO diet contained 9.3% safflower oil and LSO 
diet contained 1.1% safflower oil and 8.2% beef tallow by 
weight. Mean + SEM. n=40. Values were significantly 
different between HSO and LSO: * P<0.05 
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Rats fed the LSO diet ate more food than rats fed the HSO diet 
during the 31 feeding days. The mean daily food intakes of 40 rats per 
diet group were 13.09 + 1.09 g/day (Mean + SEM) for the HSO group and 
14.23 + 0.36 g/day for the LSO group. The difference was statistically 
significant (P<0.05). As shown in Figure 5, the difference in 
accumulated food intakes between the two dietary groups was 
statistically significant at 14, 28, and 31 days of feeding. The mean, 
accumulated food intakes of rats in the HSO and LSO groups were 146.12 
+ 4.94 and 165.88 + 5.64 on the 14 day, 359.30 + 7.06 and 381.18 + 8.81 
on the 28 day, and 405.88 + 10.90 and 441.18 + 10.33 on the 31 day of 
the feeding. The mean daily food intakes for the aspirin feeding 
period were 15.53 + 3.90 g/day for the HSO group and 20.00 + 4.18 g/day 
for the LSO group (Mean + SEM, n=40). There was no significant 
difference in the accumulated food intakes or in the mean daily food 
intakes between control and aspirin feeding groups. 
Body Weight Changes 
The body weight changes of rats fed the HSO or the LSO diet for 
one month are presented in Figure 6. The mean growth rate of rats 
(Mean + SEM, n=40) in the HSO group was 5.52 + 0.11 g/day and that of 
rats in the LSO group was 5.57 + 0.18 g/day during the 31 feeding days. 
The difference was not statistically significant. The mean growth 
rates (Mean + SEM, n=40) for the aspirin feeding period were 5.10 + 
0.70 g/day for the HSO group and 3.97 + 0.63 g/day for the LSO group. 
This difference was not statistically significant. 
56 
250 
200 
150 
100 
50 
—7— 
7 
DIET 
14 21 
FEEDING DAYS 
0 0 0 HSO 
28 35 
LSO 
FIGURE 6. Body weight changes of rats fed diets different in fat 
qualities. HSO diet contained 9.3% safflower oil, LSO diet 
contained 1.1% safflower oil and 8.2% beef tallow by weight. 
Mean + SEM. n=40. None of the values were significantly 
different between HSO and LSO 
Fatty Acid Composition of Epididymal Fat Pads 
Fatty acid compositions as weight per cent of total fatty acids of 
epididymal fat pads are shown in Table 5. Dietary treatments markedly 
changed the composition of fatty acids in the epididymal fat pads. Fat 
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pads from rats fed the HSO diet contained significantly higher 
eicosanoid precursor fatty acids (linoleic and arachidonic acids) at 
the expense of other fatty acids (oleic, palmitic, stearic, myristic, 
linolenic acids). Epididymal fat pads from the HSO group contained 
60.77% linoleic acid (7.5-times the LSO group), 18.14% oleic acid, 
18.05% palmitic acid, and 0.71% arachidonic acid (14.2-times the LSO 
group). Epididymal fat pads from the LSO group contained 55.67% oleic 
acid (3.1-times the HSO group), 31.29% palmitic acid (1.7-times the HSO 
group), and 8.05% linoleic acid. All the observed differences in the 
composition of fatty acids between the two dietary groups were 
statistically significant. On the other hand, aspirin feeding (50 
mg/Kg bw/day) for 2 days did not cause any significant difference in 
the fatty acid composition of epididymal fat pads compared with the 
control (data not shown). 
Free Fatty Acid Release 
Compositions of free fatty acids of norepinephrine-treated 
adipocytes during a 15-min incubation are shown in Table 6. 
Norepinephrine-treated adipocytes from rats fed HSO diet released 
significantly greater proportions of linoleic acid (61.96%, 5.8-times 
the LSO), less palmitic, oleic, and myristic acids (18.50%, 15.63%, and 
0.85%; 0.68-, 0.28-, and 0.3-times the LSO group, respectively) during 
the 15-min incubation. Composition of free fatty acids released from 
norepinephrine-treated adipocytes during a 15-min incubation from rats 
fed the LSO diet was 55.75% oleic acid, 27.25% palmitic acid, and 
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TABLE 5. Effect of diets different in fat qualities on the 
fatty acid composition of epididymal fat pads of 
rats 
Diet 
Fatty Acid HSO LSO 
weight per cent 
14:0^ 0.70 + 0.05 2.15 + 0.03* 
15:0 18.05 + 0.28 31.29 + 
* 
0.81 
18:0 1.50 + 0.06 2.32 + 0.82* 
18:1 18.14 + 0.36 55.67 + 
* 
0.59 
18:2 60.77 + 0.49 8.05 + 
* 
0.62 
18:3 0.16 + 0.04 0.48 + 0.04* 
20:4 0.71 + 0.03 0.05 + 0.01* 
^ean + SEM. n=8. HSO diet contained 9.3% safflower oil 
and LSO diet contained 1.1% safflower oil and 8.2% beef tallow 
by weight. Values were significantly different from HSO: * P<0.05. 
^Number of carbons :number of double bonds. 
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10.72% linoleic acid. Norepinephrine treatment did not cause any-
significant changes in the composition of free fatty acids compared to 
the control (data not shown). 
There was no significant interaction in per cent of composition of 
each free fatty acid between diets (HSO, LSO) and groups (CON, ASP), 
diets and incubation conditions (0 min-Con, 15 min-Con, 15 min-Norepi), 
groups and incubation conditions, or among diets and groups and 
incubation conditions. 
The effect of diets on the concentrations of free fatty acids 
released from isolated adipocytes are presented in Table 7. As shown 
in Table 7, adipocytes of HSO group released significantly greater 
amounts of stearic and linoleic acids than did adipocytes of the LSO 
group. Adipocytes of HSO group released 44.25 + 5.27 ug stearic acid 
(1.7-times the LSO group), and 1240.54 + 211.53 u<3 linoleic acid 
(12.1-times the LSO group) per 10® cells. Adipocytes of HSO group 
released greater amounts of arachidonic acid (11.61 + 4.91 ug/10^ 
cells, 2.8-times the LSO group), but the difference was not 
statistically significant. On the other hand, adipocytes of the LSO 
group released significantly greater amount of oleic acid (531.87 + 
57.93 Mg, 1.7-times the HSO group) per 10® cells. Adipocytes of HSO 
group released significantly (P<0.05) greater amounts of total free 
fatty acids than adipocytes of LSO group (HSO, 2002.17 + 391.73 wg/10® 
cells, 2.1-times the LSO group). 
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TABLE 6. Effect of diets different in fat qualities on the composition 
of free fatty acids of rat adipocytes^ 
Diet 
FFA HSO LSO 
weight per cent 
14:0^ 0.85 + 0.08 2.54 + 0.21 
16:0 18.50 + 1.00 27.25 + 1.24 
18:0 2.21 + 0.51 2.66 + 0.51 
1—1 CD «—
i 
15.63 + 0.66 55.75 + 0.63 
18:2 61.96 + 1.21 10.72 + 1.33 
18:3 0.27 + 0.12 0.65 + 0.15 
20:4 0.58 + 0.13 0.43 + 0.31 
^Mean + SEM. n=8. HSO diet contained 9.3% safflower oil, 
and LSO diet contained 1.1% safflower oil and 8.2% beef tallow 
by weight. Adipocytes were isolated from epididymal fat pads of 
rats, preincubated for 30 min and incubated with norepinephrine 
(10 M) for 15 min at 37°C. Values were significantly 
different from HSO: P<0.05. 
from HSO: * P<0.05. 
^Numbers of carbons:numbers of double bonds. 
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TABLE 7. Effect of diets different in fat qualities on the 
concentration of free fatty acids released from rat 
adipocytes^ 
Diet 
Free Fatty Acid HSO LSO 
Atg/lO® cells 
14:0^ 17.02 + 1.07 24.23 + 4.74 
16:0 370.40 + 81.16 259.97 + 48.33 
18:0 44.25 + 5.27 25.38 + 4.97 
18:1 312.94 + 124.41 531.87 + 57.93 
18:2 1240.54 + 211.53 102.27 + 15.52 
18:3 5.41 + 0.71 6.20 + 1.45 
20:4 11.61 + 4.91 4.10 + 0.32 
Total 2002.17 + 391.73 954.02 + 124.28' 
^Mean + SEM. n=8. HSO diet contained 9.3% safflower oil, 
and LSO diet contained 1.1% safflower oil and 8.2% beef tallow 
by weight. Adipocytes were isolated from epididymal fat pads 
of rats, preincubated for 30 rain, and incubated with 
norepinephrine (10 M) for 15 min. Values were 
significantly different from HSO: * P<0.05. 
^Number of carbons:number of double bonds. 
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The release of total free fatty acids in aspirin-fed group was 
983.5 + 149.9 wg, and that in the control group was 1748.5 + 215.5 ug 
(P<0.05) per 10® cells (n=24). On the other hand, aspirin feeding did 
not alter the composition of released free fatty acids compared with 
the control group. 
The effect of incubation conditions (incubation time and 
norepinephrine treatment) on the concentrations of free fatty acids 
released from isolated adipocytes is presented in Table 8. Even though 
some fatty acids were released in greater average amounts during a 
15-min incubation or by the norepinephrine treatment compared with the 
control, none of the differences were statistically significant. The 
concentration of total free fatty acids released from adipocytes of 0 
min-control (0 min. Con), 15 min-Control (15 rain, Con), and 15 min-
norepinephrine (15 min, Norepi) was 1346.1, 1273.7, and 1478.1 ug/lO^ 
cells. There was no interaction in the concentration of each free 
fatty acid between diets (HSO, LSO) and groups (CON, ASP), diets and 
incubation conditions (0 min-Con, 15 min-Con, 15 min-Norepi), groups 
and incubation conditions, or among diets and groups and incubation 
conditions. 
2-Deoxy Glucose Transport 
Figure 7 and Figure 8 show effect of diets and aspirin feeding on 
2-deoxy glucose (2-DG) transport into isolated adipocytes. At the end 
of one-month feeding, rats were fed diets with (CON) or without aspirin 
(ASP, 50 mg/Kg bw/day) for 2 days ad libitum. Isolated adipocytes were 
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TABLE 8. Effect Of incubation conditions on the concentration of free 
fatty acids of rat adipocytes^ 
Incubation condition 
FFA 
0 min 15 rain 
SEN Con Con Norepi 
jug/lO® cells 
14:0^ 17.86 15.55 17.07 3.39 
16:0 292.87 301.43 336.24 49.86 
18:0 29.70 35.90 29.73 5.93 
18:1 325.97 345.73 428.98 59.08 
18:2 663.03 559,76 647.36 131.40 
18:3 6.25 5.10 4.75 2.12 
20:4 10.42 10.23 13.96 3.44 
Total 1346.10 1273.70 1478.10 194.10 
^n=16. Adipocytes were isolated from epididymal fat pads, 
preincubated for 30 rain, and incubated with (Norepi) or without (Con) 
norepinephrine at 10 M at 37®C. None of the values 
were significantly different in rows. 
^Number of carbons:number of double bonds. 
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preincubated with KRB buffer containing 3% BSA for 30 min prior to 
addition of radiolabeled glucose. 
As shown in Figure 7, adipocytes from rats fed the HSO diet had 
significantly greater 2-DG transport compared with adipocytes from the 
LSO-fed rats during a 10-min incubation. Nanomoles (Mean + SEM, n=48) 
of 2-DG transport into 10^ adipocytes of HSO and LSO groups were 4.48 + 
0.43 and 2.96 + 0.19 at 2-min (P<0.05), 8.66 + 0.79 and 6.31 + 0.54 at 
5-min (P<0.05), and 12.38 + 1.18 and 10.22 + 1.17 at 10-min (P<0.05) 
incubation times, respectively. 
Aspirin feeding (50 mg/Kg/day, 2 days) did not change 2-DG 
transport into adipocytes significantly compared with the control 
group. 
Nanomoles (Mean + SEM, n=48) of 2-DG transport into 10^ adipocytes 
of control rats and aspirin fed rats were 3.34 + 0.30 and 4.11 + 0.38 
at 2-min, 7.07 + 0.74 and 7.90 + 0.66 at 5-min, and 12.02 + 1.38 and 
10.11 + 0.77 at 10-min incubation times, respectively. 
Effects of in vitro treatments within each diet group are 
presented in Tables 9-11. A large variability was found in the 2-DG 
transport data of ^  vitro treatments of control (Con), norepinephrine 
(N), anti-PGE (AntiE), anti-PGE plus norepinephrine (AntiEN), aspirin 
(Asp), and aspirin plus norepinephrine (AspN) between adipocyte 
preparations. When 2-DG transport data (nanomoles 2-DG transport into 
10® cells during a 10 min incubation) were treated statistically to 
compare effects of in vitro treatments, no effects were significant. 
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FIGURE 7. Effects of diets on adipocyte 2-deoxy glucose transport. 
Mean + SEM. n=48. Nanomoles 2-DG transport into 10 cells 
during a 10 min incubation. Rats were fed diets with 9.3% 
safflower oil (HSO) or 1.1% safflower oil plus 8.2% beef 
tallow for 1 mon. Adipocytes were isolated from epididyraal 
fat pads, preincubated 30 rain, and incubated for 10 min at 
37°. Values were different between HSO and LSO: * P<0.05 
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FIGURE 8. Effects of aspirin feeding on adipocyte 2-deoxy glucose 
transport. Mean + SEM. n=48. Nanomoles 2-DG transport 
into 10 cells during a 10 min incubation. Rats were fed 
diets with (ASP) or without (CON) aspirin at 50 mg/Kg bw/day 
for 2 days. Adipocytes were isolated from epididymal fat 
pads, preincubated 30 min, and incubated for 10 min at 37°C. 
None of the values were significantly different between CON 
and ASP 
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This statistical insignificancy might be caused by the daily 
variabilities among adipocyte preparations. To best demonstrate the 
effect of ^  vitro treatments of those eicosanoid modifiers on 2-DG 
transport into adipocytes and to eliminate the daily variabilities 
among adipocyte preparations, 2-DG transport data were converted into 
ratio to the control (control=1.00) in each diet group and analyzed 
statistically. 
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The treatment of norepinephrine at 10 M decreased 2-DG transport 
into adipocytes, compared with the control, in the HSO-CON group. In 
the HSO-CON group, at the 2-min incubation time, norepinephrine, 
norepinephrine plus aspirin (23 mM), or norepinephrine plus anti-PGE 
(167 al per 1,600 wl final incubation mixture) decreased 2-DG transport 
compared with the control. At the 5-min incubation time, 
norepinephrine, norepinephrine plus aspirin, and norepinephrine plus 
anti-PGE tended to decrease 2-DG transport compared with the control, 
but not significantly. At the 10-min incubation time, norepinephrine 
tended to decrease 2-DG transport. When norepinephrine was treated 
along with aspirin or anti-PGE, the decrement in 2-DG transport became 
statistically significant. On the other hand none of the 
norepinephrine treatments significantly affected 2-DG transport into 
adipocytes in other diet groups iji vitro. 
Effects of ^  vitro aspirin treatments (Asp, 23 mM) in each diet 
group are shown in Table 10. Aspirin treatment at 23 mM decreased 2-DG 
transport into adipocytes compared with the control in the HSO-CON 
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TABLE 9. Effect of norepinephrine on adipocyte 2-deoxy glucose 
transport in vitro 
Treatment N AspN AntiEN 
Diet group 
ratio to control 
2 rain 
HSO-CON^ 
HSO-ASP 
LSO-CON 
LSO-ASP 
0.56 
0.96 
1.41 
0.94 
+ 
+ 
+ 
+ 
0.15* 
0.05* 
0.34* 
0.22* 
0.50 + 0.11® 
1.05 + 0.33? 
1.12 + 0.19* 
0.92 + 0,15 
0.65 
0.86 
0.79 
0.74 
+ 
+ 
+ 
+ 
0.13® 
0.08* 
5 min 
HSO-CON 0.80 + 0.12* 0.93 + 0.26* 0.89 + 0.32® 
HSO-ASP 0.89 + 0.20* 0.87 + 0.13* 0.84 + 0.11* 
LSO-CON 1.04 + 0.30* 1.12 + 0.20* 
1.19 + 0.11 
0.71 + 0.08* 
LSO-ASP 1.05 + 0.06 1.48 + 0.49 
10 min 
HSO-CON 0.90 + 0.11* 0.74 + 0.09® 0.74 + 0.08® 
HSO-ASP 0.92 + 0.16* 1.02 + 0.11* 0.91 + 0.11* 
LSO-CON 1.47 + 0.50* 1.43 + 0.64* 1.02 + 0.16* 
LSO-ASP 1.70 + 0.37* 1.77 + 0.52* 1.60 + 0.32* 
^n=4. Mean + SEM. The nanomoles of 2-DG transport/10 cells of 
control treatments (ratio=1.00) in diet groups (HSO-CON, HSO-ASP, 
LSO-CON, and LSO-ASP) at 2-, 5-, and 10-min incubation times are: 
2-min, 5.03 + 1.38, 5.92 + 2.22, 2.93 + 0.54, and 3.41 + 0.89: 
5-min, 10.54 + 3.87, 9.85 + 2.79, 5.49 + 1.06, and 6.31 + 1.55; 
10-min, 16.41 + 6.43, 12.01 + 3.57, 7.54 + 1.47, and 6.45 + 2.07. 
The letter B as a superscript shows a significant difference 
from the control: P<0.05. 
^Rats were fed diets with 9.3% safflower oil (HSO) or 1.1% safflower 
oil plus 8.2% beef tallow (LSD) by weight. At the end of 1 mon feeding, 
rats were fed diets with (ASP) or without (CON) aspirin (50mg/Kg bw/day) 
for 2 days. Isolated adipocytes from epididymal fat_Dads were preincubated 
for 30 min and incubated with norepinephrine (N) (10 ^  M), or aspirin 
(23 mM) plus norepinephrine (10 M) (AsgN), or Anti-PGE 
(167 ML/1200 ML) plus norepinephrine (10 M) (AntiEN). 
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group. In HSO-CON group, aspirin treatment tended to decrease 2-DG 
transport compared with the control consistently during a 10-min 
incubation. The decrement was statistically significant at the 10-min 
incubation time. In HSO-CON group, aspirin plus norepinephrine also 
tended to decrease 2-DG transport consistently during a 10-min 
incubation. The decrements in 2-DG transport by aspirin plus 
norepinephrine were significant at the 2- and 10-min incubation times. 
On the other hand, aspirin plus norepinephrine significantly increased 
2-DG transport compared with the control in the LSO-ASP group at the 
10-min incubation time. None of the aspirin treatments significantly 
affected 2-DG transport into adipocytes in the HSO-ASP group or in the 
LSO-CON group. 
Effects of in vitro anti-PGE on 2-DG transport into isolated 
adipocytes in each diet group are shown in Table 11. 
Anti-PGE (167 ul per 1,600 M1 final incubation mixture) decreased 
2-DG transport into adipocytes compared with the control in the HSO-CON 
group. The decrement was statistically significant at an early time 
point; 2-min incubation time. Anti-PGE plus norepinephrine 
significantly decreased 2-DG transport into adipocytes at 2- and 10-min 
incubation times. None of the anti-PGE treatments significantly 
affected 2-DG transport into isolated adipocytes in other diet groups. 
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TABLE 10. Effect Of aspirin on adipocyte 2-deoxy glucose transport in 
vitro® 
Treatment Asp AspN 
Diet group 
ratio to control 
2 min 
HSO-CON^ 0.98 + 0.15^ 0.50 + 0.11® 
HSO-ASP 1.07 + 0.30V 1.05 + 0.33* 
LSO-CON 1.23 + 0.25* 
0.69 + 0.11 
1.12 + 0.19* 
LSO-ASP 0.92 + 0.15 
5 min 
HSO-CON 0.79 + 0.17^ 0.93 + 0.26* 
HSO-ASP 0.85 + 0.05? 0.87 + 0.13* 
LSO-CON 1.34 + 0.37* 1.12 + 0.20? 
LSO-ASP 1.05 + 0.08 1.19 + 0.11 
10 min 
HSO-CON 
HSO-ASP 
0.78 + 0.10® 
1.11 + 0.05* 
0.74 
1.02 
+ 
+ 
0.08® 
0.11* 
0.34* 
0.32® 
LSO-CON 1.54 + 0.26* 1.43 + 
LSO-ASP 1.56 + 0.27 1.77 + 
^n=4. Mean + SEM. The nanomoles of 2-DG transport/10 cells 
control treatments (ratio=1.00) in each diet group (HSO-CON, HSO-ASP, 
LSO-CON, and LSD-ASP) at 2-, 5-, and 10-min incubation times are: 
2-min, 5.03 + 1.38, 5.92 + 2.22, 2.93 + 0.54, and 3.41 + 0.89: 
5-min, 10.54 + 3.87, 9.85 + 2.79, 5.49 + 1.06, and 6.31 + 1.55: 
10-min, 16.41 + 6.43, 12.01 + 3.57, 7.54 + 1.47, and 6.45 + 2.07. 
The letter B as a superscript shows a significant difference from 
the control: P<0.05. 
^Rats were fed diets with 9.3% safflower oil (HSO) or 1.1% 
safflower oil plus 8.2% beef tallow (LSO) by weight. At the end of 
1 mon feeding, rats were fed diets with (ASP) or without (CON) aspirin 
at 50 mg/Kg bw/day for 2 days. Isolated adipocytes from epididymal 
fat pads were preincubated for 30 min and incubated with.aspirin 
(23 mM, Asp) or aspirin (23 mM) plus norepinephrine (10 M). 
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TABLE 11. Effect Of anti-PGE on adipocyte 2-deoxy glucose transport in 
vitro^ 
Treatment AntiE AntiEN 
Diet group 
ratio to control 
2 min 
HSO-CON^ 0.55 ± 0.16® 0.65 + 0.13® 
HSO-ASP 1.23 ± 0.32* 0.86 + 0.08* 
LSO-CON 0.96 ± 0.11^ 0.79 + 0.23* 
LSO-ASP 0.91 + 0.11 0.74 + 0.12* 
5 min 
HSO-CON 0.94 + 0.14? 0.89 + 0.23* 
HSO-ASP 0.89 + 0.04" 0.84 + 0.11* 
LSO-CON 0.99 ± 0.22" 0.71 + 0.24* 
LSO-ASP 0.90 + 0.15 1.48 + 0.49* 
10 min 
HSO-CON 0.95 + 0.10* 0.74 + 0.08? 
HSO-ASP 0.89 + 0.08" 0.91 + 0.11* 
LSO-CON 1.63 + 0.24* 1.02 + 0.16* 
LSO-ASP 1.67 + 0.21 1.60 + 0.32* 
n=4. Mean + SEM. The nanomoles of 2-DG transport/10 cells 
of control treatments (ratio=1.00) in diet groups (HSO-CON, HSO-ASP, 
LSO-CON, and LSO-ASP) at 2-, 5-, and 10-min incubation times are: 
2-min, 5.03 + 1.38, 5.92 + 2.22, 2.93 + 0.54, and 3.41 + 0.89; 
5-min, 10.54 + 3.87, 9.85 + 2.79, 5.49 + 1.06, and 6.31 + 1.55: 
10-min, 16.41 + 6.43, 12.01 + 3.57, 7.54 + 1.47, and 6.45 + 2.07. 
The letter B as a superscript shows a significant difference from 
the control; P<0.05. 
^Rats were fed diets with 9.3% safflower oil (HSO) or 1.1% 
safflower oil plus 8.2% beef tallow (LSO) by weight. At the end of 
1 mon feeding, rats were fed diets with (ASP) or without (CON) aspirin 
(50 mg/Kg bw/day) for 2 days. Isolated adipocytes from epididymal 
fat pads were preincubated for 30 min and incubated without (control) 
or with Anti-PGE (167ML per 1600 WL_final incubation mixture) 
or Anti-PGE plus norepinephrine (10 M) (AntiEN). 
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Correlation Coefficients 
Correlation coefficients were estimated between per cent 
compositions of fatty acids in epididymal fat pads and per cent 
compositions of free fatty acids released from isolated adipocytes. 
Correlation coefficients also were estimated between rates of 2-DG 
transport into adipocytes during a 5-min incubation (nanomoles 2-DG 
transport per min) and rates of free fatty acid release during a 15-min 
incubation (ug FFA per min) in adipocytes (Table 12). 
The content of each fatty acid in the epididymal fat pads was 
positively correlated with the content of the same fatty acid released 
from isolated adipocytes at the 0-min incubation time (14:0, r=+0.76, 
P=0.0001; 16:0, r=+0.92, P=0.0001; 18:0, r=+0.56, P=0.0001; 18:1, 
r=+0.99, P=0.0001; 18:2, r=+0.99, P=0.0001; 18:3, r=+0.78, P=0.0001; 
n=96). 
The release of linoleic acid (ug) from adipocytes was positively 
correlated with 2-DG transport in the HSO-CON group (r=+0.56, P=0.0153, 
n=24) and in the LSO-ASP group (r=+0.74, P=0.0004, n=24). The release 
of arachidonic acid was positively correlated with 2-DG transport in 
the HSO-CON group (r=+0.63, P=0.0265, n=24). The release of linolenic 
acid was negatively correlated with 2-DG transport in the HSO-CON, HSO-
ASP, and LSO-ASP groups (HSO-CON, r=-0.72, P=0.0007; HSO-ASP, r=-0.94, 
P=0.0001; LSO-ASP, r=-0.52, P=0.0813; n=24). The release of oleic acid 
was positively correlated with 2-DG transport in the HSO-CON (r=+0.72, 
P=0.0007, n=24) and LSO-ASP (r=+0.56, P=0.0162, n=24) groups. The 
TABLE 12. Correlation coefficients between free fatty acid release and 
2-deoxy glucose transport 
FFA 
Diet Group 
14:0 16:0 18:0 18:1 18:2 18:3 20:4 Total FFA 
HSO-CON r 
P 
n 
HSO-ASP r 
P 
n 
LSO-CON r 
P 
n 
LSO-ASP r 
P 
n 
+0.28 
.0265 
24 
+0.78 
.0001 
24 
+0.11 
,6559 
24 
-0.31 
.2082 
24 
+0.40 
.1006 
24 
-0.52 
.0261 
24 
+0.15 
.5540 
24 
+0,66 
.0030 
24 
-0,12 
.6253 
24 
+0-61 
.0072 
24 
+0,28 
.2629 
24 
+0.60 
.0084 
24 
+0.72 
.0007 
24 
+0.47 
.0467 • 
24 
+0.10 
.6885 
24 
+0.56 
.01620 
24 
+0.56 
.0153 
24 
+0.04 
.8649 
24 
+0.13 
.6123 
24 
+0.74 
.0004 
24 
-0.72 
.0007 
24 
-0.94 
.0001 
24 
+0.42 
.1726 
24 
-0.52 
.0813 
24 
+0.63 
.0265 
24 
+0,49 
.0107 
24 
-0.41 
.0920 
24 
+0.05 
.8390 
24 
+0.60 
.0090 
24 
-0.04 
.8619 
24 
-0.13 
.6148 
24 
+0.61 
.0068 
24 
-J 
w 
^Correlation coefficients were estimated between rates of 2-DG 
transport into adipocytes during a 5-min incubation (nanomoles 2-DG 
transport per min) and rates of free fatty acid release during a 15-min 
incubation (yg FFA per min) by adipocytes. Rats were fed diets with 
9.3% safflower oil (HSO) or 1.1% safflower oil plus 8.2% beef tallow (LSO) 
by weight. At the end of 1 mon feeding, half of the rats were fed diets 
(either HSO or LSO) with (ASP) or without (CON) aspirin (50mg/Kg bw/day) for 
2 days. Isolated adipocytes from epididymal fat pads were preincubated 
for 30 min and incubated for 15 min at 37°C. 
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release of stearic acid was positively correlated with 2-DG transport 
in the HSO-ASP group (r=+0.61, P=0.0072, n=24). The release of 
palmitic acid was negatively correlated with 2-DG transport in the HSO-
ASP group (r=-0.52, P=0.0261, n=24), but positively correlated in the 
LSO-ASP group (r=+0.66, P=0.0030, n=24). The release of myristic acid 
was positively correlated with 2-DG transport in the HSO-ASP group 
(r=+0.78, P=0.0001, n=24), The release of total free fatty acids were 
positively correlated with 2-DG transport in the HSO-CON group and the 
LSO-ASP group (HSO-CON, r=+0.60, P=0.0090; LSO-ASP, r=+0.61, P=0.0008; 
n=24). 
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DISCUSSION 
Because stored fatty acids in adipose tissue reflect the dietary 
fatty acid composition, investigators have used this tissue to study 
effects of different diets on eicosanoid production or intracellular 
metabolism affected by endogenous eicosanoids. Isolated adipocytes 
were used as a model to study the relationship between endogenous 
eicosanoid production and glucose transport into cells. The objective 
was to determine if the dietary fatty acids actually were reflected in 
the composition of fatty acids in the epididymal fat pads, if the 
composition of fatty acids in the fat pads were reflected in the 
composition of fatty acids released from isolated adipocytes; and 
consequently, if the amounts of free fatty acids in adipocytes would 
affect glucose transport by isolated adipocytes. Three eicosanoid 
modifiers were used; aspirin (feeding and treatment vitro) to 
inhibit eicosanoid synthesis, antiserum to PGE to specifically inhibit 
PGE, and norepinephrine to accelerate eicosanoid synthesis by 
stimulating release of free fatty acids including eicosanoid 
precursors. 
Rats fed the LSO diet ate significantly more food than rats fed 
the HSO diet during the 31 feeding days (13.09 + 1.09 g/day vs. 14.23 
+ 0.36 g/day, HSO vs. LSO). However, neither the mean body weights nor 
the mean weights of fat pads were different between the two diet 
groups. 
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Safflower oil contains approximately 74% linoleic acid, 13% oleic 
and palmitoleic acids, and 7% palmitic acid. Beef tallow contains 29% 
palmitic acid, 48% oleic acid, and 16% stearic acid (21). Therefore, 
the observed results show that the qualities of dietary fats were 
directly reflected in the fatty acid composition of epididymal fat 
pads. 
This result is consistent with previous studies; dietary fatty 
acids were readily incorporated into the depot fat (61). The 
composition of fatty acids in the epididymal fat pads was also directly 
reflected in the composition of free fatty acids released from basal or 
norepinephrine-treated adipocytes during a 15-min incubation. The 
correlation coefficients (P<0.05) between per cent composition of 
individual fatty acids in the epididymal fat pads and per cent 
composition of the same fatty acids released from isolated adipocytes 
were +0.76, +0.92, +0.56, +0.99, and +0.78 for myristic, palmitic, 
stearic, oleic, linoleic, and linolenic acids. This result is 
different from the report of Christ and Nygteren (13) who reported that 
a catecholamine (epinephrine, 1 jug/mL) caused a specific release of 
linoleic acid, linolenic acid, and arachidonic acid compared with the 
other fatty acids from adipose tissue during 1 h incubation. 
Aspirin (50 mg/Kg bw/day, 2 days) did not significantly alter 
concentrations or compositions of fatty acids in the epididymal fat 
pads compared with the controls. The aspirin feeding did not alter the 
composition of free fatty acids released from adipocytes compared with 
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the control, either. But the aspirin feeding significantly decreased 
concentrations of free fatty acids released from adipocytes (CON, 
5,120.7 Mg/10® cells, l.B-times the ASP). 
Isolated adipocytes from rats fed the HSO diet had significantly 
greater 2-DG transport during the 10-min incubation time compared with 
the LSO. The results suggest that the dietary linoleic acid content 
may modulate adipocyte glucose transport. 
As shown in Figure 7, aspirin feeding did not significantly affect 
2-DG transport into adipocytes during a 10-min incubation. 
The observed, 2-DG transport values are in the range of previous 
reports. Olefsky (64) reported that in the basal state, 2-DG transport 
into isolated rat adipocytes was 7.3 nanomoles per min per 10® cells 
during a 3-min incubation at 24°C. Wieringa and Krans (93) reported 
that 2-DG transport into isolated adipocytes was 8.2 nanomoles/5X10^ 
cells during a 3-min incubation in the basal state. In a review paper, 
Czech (18) claimed that the D-glucose transport system activity of fat 
cells showed a five-fold difference in apparent of transport 
between two representative experiments and emphasized the variability 
between cell preparations. Significant variability in absolute values 
of adipocyte glucose transport and utilization among cell preparations 
is well known. 
Norepinephrine, norepinephrine plus aspirin, or norepinephrine 
plus anti-PGE decreased 2-DG transport into adipocytes compared with 
the control in the HSO-CON group, but not in other groups. In the HSO-
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CON group, the release of total free fatty acid was positively (P<0.05) 
correlated with 2-DG transport. Release of linoleic acid, arachidonic 
acid, and oleic acid was positively (P<0.05) correlated with 2-DG 
transport, too. But the release of linolenic acid was negatively 
(P<0.05) correlated with 2-DG transport. Among these free fatty acids, 
the effect of linoleic acid might be the greatest since the release of 
linoleic acid is in the greatest amount in the HSO-CON group. 
The release of total free fatty acids was positively (P<0.05) 
correlated with 2-DG transport in the LSO-ASP group, too. Release of 
linoleic acid, oleic acid, stearic acid, and palmitic acid were also 
positively (P<0.05) correlated with 2-DG transport. Among these free 
fatty acids, the effect of oleic acid might be the greatest since the 
release of oleic acid is in the greatest amount in the LSO groups. As 
mentioned in "Review of Literature", reports about the effect of 
catecholamine on adipocyte glucose transport or metabolism are 
equivocal. Some reported positive effects (90, 74, 44, 45) and some 
reported negative effects (10, 79, 80, 93). 
Aspirin treatment in vitro significantly decreased 2-DG transport 
into adipocytes compared with the controls in the HSO-CON group. The 
results suggest that endogenous eicosanoids may have a positive role in 
adipocyte glucose transport. The preliminary results in the present 
study showed that isolated rat adipocytes produced appreciable amounts 
of eicosanoids (PGE^, PGE2, PGI2 and PGF2a ® decreasing order for 
amounts of eicosanoids produced per unit number of cells). The 
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synthesis of PGE^, PGE2, and PGF2Qf but not PGI2 was increased by 
incubating cells with norepinephrine at 10 M for 30 min. Aspirin 
treatment inhibits synthesis of group-2 eicosanoids. Adipocytes of the 
LSO group contained smaller eicosanoid precursor stores. Therefore, 
the ability of adipocytes of the HSO-ASP or the LSO-CON groups to 
synthesize eicosanoids would be much smaller than that of adipocytes of 
the HSO-CON group. This differential rate of eicosanoid synthesis 
might be the reason for the non-significant effect of aspirin treatment 
on 2-DG transport into isolated adipocytes in the HSO-ASP and the LSO-
CON groups. 
This result is consistent with several reports in which inhibitors 
of eicosanoids, such as indomethacin (2) and L8027 (53), inhibited 
glucose transport into isolated rat adipocytes. The results suggest 
that endogenous eicosanoids may have a positive role in adipocyte 
glucose transport. 
On the other hand, aspirin plus norepinephrine ^  vitro 
significantly increased 2-DG transport into adipocytes compared with 
the control in the LSO-ASP group. Aspirin treatment itself did not 
significantly change 2-DG transport compared with the control. 
Adipocytes of the LSO-ASP group may have synthesized very little 
eicosanoids due to the effect of aspirin and the limited precursor 
availability. Therefore, the increment in 2-DG transport by aspirin 
plus norepinephrine may be attributed to the effect of norepinephrine 
rather than aspirin. Actually, the correlation coefficiency between 
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total free fatty acids and 2-DG transport in the LSO-ASP group was 
positive (r=+0.58, P=0.0115, n=24). 
Anti-PGE significantly decreased 2-DG transport into isolated 
adipocytes in the HSO-CON group. The results suggest a positive effect 
of PGE on adipocyte glucose transport. On the other hand, anti-PGE did 
not change 2-DG transport in the HSO-ASP group or in the LSG groups 
which might be attributed to the low level of eicosanoid precursors 
available. 
As mentioned in "Review of Literature", most iji vitro experiments 
which used isolated fat cells resulted in a positive role of PGE^ (11, 
35, 94) and PGE2 (2, 71) in glucose transport. PGF2a reported to 
have a tendency of increasing glucose transport and glucose metabolism 
in isolated adipocytes but the results were not statistically 
significant (71). 
The release of linoleic acids from isolated adipocytes was 
positively correlated (P<0.05) with 2-DG transport into adipocytes 
(HSO-CON, r=+0.56; LSO-ASP, r=+0.74; n=24). The release of arachidonic 
acid was positively correlated (P<0.05) with 2-DG transport in the HSO-
CON group (r=+0.63; n=24). These significant, positive correlations 
between precursors of eicosanoids and 2-DG transport suggest that 
eicosanoids have a positive role in adipocyte glucose transport. On 
the other hand, the release of linolenic acid was negatively (P<0.05) 
correlated with 2-DG transport (HSO-CON, r=-0.72 HSO-ASP, r=-0.94; LSO-
ASP, r=-0.52; LSO-ASP, r=-0.52; n=24). Alpha-linolenic acid or its 
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products inhibit synthesis of group-2-eicosanoids by competing with 
linoleic acid for A®-desaturase (4, 66). This inhibition of 
a-linolenic acid on the synthesis of y-linolenic acid might be the 
reason for the observed, negative correlations between the release of 
a-linolenic acid and 2-DG transport. 
The release of oleic acid, stearic acid, and myristic acid also 
were positively correlated (P<0.05) with 2-DG transport in certain diet 
groups (oleic acid in the HSO-CON and LSO-ASP groups, stearic acid in 
the ASP groups, myristic acid in the HSO-ASP group). The release of 
palmitic acid was positively correlated with 2-DG transport in the LSO-
ASP group but negatively correlated in the HSO-ASP group. The 
mechanism of effects of theses free fatty acids on 2-DG transport are 
not known. 
In rat fat cells, a biphasic response of glucose transport to 
p-receptor agonist of catecholamines, such as isoproterenol, and other 
cAMP stimulators has been reported (45, 48). A low concentration of 
/3-agonists stimulated basal glucose transport into adipocytes by 
increasing and high concentrations of ^-agonists inhibited it by 
decreasing These results suggest that catecholamines and 
/3-agonists may modulate glucose transport by affecting the glucose 
transporter. 
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SUMMARY 
A high PUFA (HSO) diet increased the content of eicosanoid 
precursors in epididymal fat pads compared with low PUFA 
(LSO) diet group. 
The composition of fatty acids in the fat pad was directly 
reflected in the composition of free fatty acids released 
from isolated adipocytes. 
HSO significantly increased glucose transport into isolated 
rat adipocytes compared with the LSO. 
Aspirin feeding (ASP) did not significantly affect glucose 
transport into isolated rat adipocytes compared with the 
control group (CON). 
Aspirin and anti-PGE in vitro significantly decreased 
glucose transport into rat adipocytes in the HSO-CON group 
compared with the controls. 
Norepinephrine decreased glucose transport into isolated rat 
adipocytes in the HSO-CON group, and aspirin plus 
norepinephrine increased it in the LSO-ASP group compared 
with the controls. 
The release of linoleic acid, arachidonic acid, oleic acid, 
and total free fatty acids was positively correlated with 
glucose transport into adipocytes. 
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CONCLUSION 
Dietary fatty acids affect the fatty acid composition of fat pad, 
and that affects adipocyte glucose transport. High PUFA diet increases 
adipocyte glucose transport while aspirin or anti-PGE decreasing it. 
These results suggest that the effect is via eicosanoids. PGE seems to 
be particularly involved. 
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